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Abstract 
With the aging population on the rise, the prevalence of heart failure is expected to increase in 
the coming years. Heart failure is independently correlated with cognitive decline and has a 
negative impact on quality of life, morbidity and mortality. Reduced cardiac output (Q) and 
cerebral blood flow (CBF) are proposed mechanistic links between heart failure and cognitive 
decline; however, reports are limited to the supine position and the response to an everyday 
upright posture is unknown. The purpose of this thesis was to primarily investigate the CBF 
response to a common upright seated position encountered in daily life in heart failure patients 
compared to healthy age- and sex-matched controls. Furthermore, we sought to determine 
whether cognitive performance or cognitive-activated hemodynamics were posture-dependent in 
the heart failure group. The secondary objective of this thesis was to be inclusive to patients that 
represent those encountered in clinical practice—specifically to include patients with higher left 
ventricular ejection fractions (LVEF) and atrial fibrillation with co-existing heart failure. Our 
findings confirmed greater cognitive impairments and a low supine CBF and Q in heart failure 
compared to controls and importantly, for the first time, a greater reduction in CBF with an 
upright seated position compared to healthy age- and sex- matched controls. When a cognitive 
task was performed supine and seated, performance outcomes were independent of posture in 
heart failure patients. However, mean flow velocity through the middle cerebral artery 
(MFVMCA) increased less in response to the cognitive task seated. With regard to our secondary 
objectives, the results suggest that those with higher LVEF are equally at risk for cognitive 
decline and cerebral hypoperfusion due to a low Q. Furthermore, high variability in Q and 
MFVMCA were detected in association with the beat-to-beat variation inherent to atrial fibrillation 
and suggest that this may be an underappreciated pathway to cognitive impairments in this sub-
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group. Together, these results suggest that upright cerebral hypoperfusion throughout the day 
may contribute to cognitive decline in heart failure and create a basis for further work to be done 
with larger sample sizes. Moreover, cerebral hypoperfusion with higher LVEF and the blood 
flow variation in atrial fibrillation represent important pathways contributing to cognitive decline 
in these under investigated sub-groups.  
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1.0 Literature Review 
1.1 Definition and Epidemiology of Heart Failure 
Heart failure is characterized by a progressive loss of functional cardiomyocytes that 
disrupt the heart’s ability to generate force and thus compromises the delivery of adequate blood 
to the rest of the body (Klabunde, 2005). The loss of cardiomyocytes is initiated by an ‘index 
event’ such as a myocardial infarction, hemodynamic pressure-volume overload or a variety of 
genetic or viral cardiomyopathies. Regardless of the initial etiology, the final clinical outcome is 
a decline in the output of blood from the heart to the rest of the body (Libby et al., 2008). The 
decline in heart output that characterizes heart failure is initially compensated by the suppression 
of parasympathetic tone and elevation of the sympathetic nervous system which increases heart 
rate (HR) and peripheral resistance. This compensatory mechanism becomes pathological over 
time as long-term activation causes structural remodelling at the heart, sometimes fatal 
arrhythmias, fluid retention and increased work demand on the failing heart (Floras, 1993). Heart 
failure is associated with cognitive decline that has been attributed to reduced blood flow to the 
brain as a consequence of reduced heart output (Q-cardiac output). To date, Q and brain blood 
flow in patients with heart failure have been examined only in the supine posture. Therefore, it is 
the purpose of this thesis to examine these variables in the upright seated posture that is relevant 
to the challenges of daily life. 
Heart failure is the most common reason for older adult hospitalizations in North America 
(Liao et al., 2008). A diagnosis of heart failure places a significant burden on the patient as it is 
associated with reduced quality of life and substantial morbidity and mortality (Johansen et al., 
 2 
 
2003; Lesman-Leegte et al., 2009). A financial burden is also placed on the health care system as 
it is one of the most costly chronic conditions in North America (Liao et al., 2008). Heart failure 
is predominantly an aging disorder, increasing exponentially with older age (Roger et al., 2012; 
Ho et al., 1993). Projections to 2030 indicate that there will be a 25% increase in prevalence 
(Roger et al., 2012) coinciding with a doubling of the Canadian population that is over 65 years 
of age (Statistics Canada, 2010). Additionally, improved treatment of acute cardiovascular 
disease (CVD) such as hypertension and myocardial infarction has resulted in patients living 
longer and becoming prone to secondary cardiovascular complications, such as heart failure 
(Coats, 1998).  
Heart failure has historically been defined as either systolic or diastolic based on impairment 
of the pumping or relaxation capacity, respectively. Diastolic heart failure (DHF) is characterized 
by two main pathological conditions, diastolic dysfunction that includes abnormal left ventricular 
relaxation and filling, and combined ventricular/arterial stiffening leading to eventual concentric 
left ventricular hypertrophy (Kindermann et al., 2008). Additional diagnostic features include 
heart failure signs and symptoms and absent or mild abnormalities in pump function which is 
typically assessed clinically by left ventricular ejection fraction (LVEF) (Alagiakrishnan et al., 
2012). LVEF is the proportion of blood ejected from the left ventricle with each heart beat 
relative to total ventricular volume and has been used as a global measure of systolic function 
(Klabunde, 2005). In contrast to DHF, systolic heart failure (SHF) is predominantly associated 
with reduced pump functioning and the development of eccentric left ventricular hypertrophy 
(Maeder & Kaye, 2009). The use of the terminology SHF and DHF has recently come into 
question with the finding that patients previously diagnosed with DHF have reduced systolic 
function compared to age-matched controls (Yip et al., 2002) and have pathophysiological 
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aspects other than diastolic abnormalities (Borlaug & Paulus, 2011). To better reflect the two 
forms of heart failure, the terminology heart failure with preserved ejection fraction (HFpEF) and 
heart failure with reduced ejection fraction (HFrEF) is more appropriate and has been 
increasingly used in the literature. Epidemiological studies have suggested that the prototypical 
patient with HFpEF is elderly, female, and obese and has hypertension and atrial fibrillation 
(Philbin et al., 2000; Masoudi et al., 2003; Lenzen et al., 2004). Patients with HFpEF constitute 
a sizable 50% of the heart failure population (Owan et al., 2006; Ho et al., 2012). Despite its 
importance, most clinical investigations exclude this group and focus on HFrEF resulting in large 
gaps in knowledge about the pathophysiology and management of HFpEF. An additional goal of 
this thesis is to include this subset of the population. 
1.2 Cognitive Decline and Heart Failure 
The term ‘cardiogenic dementia’ was first used in 1977 to describe the association 
between cognitive impairment and heart failure (Lancet Editorial, 1977). Since that time there 
has been a large amount of research in this area and although the term cardiogenic dementia is no 
longer common, the relationship between heart failure and abnormal brain changes is now well 
accepted. In fact, heart failure has emerged as an independent correlate of cognitive decline 
(Trojano et al., 2003).  After adjusting for confounding variables, the presence of cognitive 
impairments was 1.96 times greater in heart failure patients than controls (Cacciatore et al., 
1998). In a recent review of the literature from 2002 to 2007, cognitive deficits have been 
reported to be present in 25 to 50% of those with heart failure (Pressler, 2008); these values are 
likely higher when considering the amount of mild deficits that go undetected. Mild cognitive 
impairment (MCI) is a transitional period between normal age-related cognitive decline and a 
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dementia diagnosis that is common in heart failure. It is often characterized by subtle changes 
that are difficult to detect. While MCI is common, severe deficits also exist in this population 
making the degree of cognitive decline highly variable. Impairments in memory, attention and 
executive function have been commonly reported but it is not known whether a typical cognitive 
profile exists for this population (Jefferson et al., 2007a; Trojano et al., 2003; Pressler, 2008). 
The presence of cognitive impairments contributes to the deterioration of health-related quality 
of life in heart failure patients as it is an independent predictor of disability, morbidity and 
mortality and influences one’s ability to perform instrumental activities of daily living (Alosco et 
al., 2012; Zuccala et al., 2001; Zuccala et al., 2003). A five-fold increase in mortality risk was 
reported when cognitive impairments were present (Zuccala et al., 2003). In addition to heart 
failure itself being age-dependent, cognitive impairments associated with heart failure become 
more prevalent with older age (Zuccala et al., 1997; Almeida & Flicker, 2001). Therefore in the 
coming years, as the heart failure incidence rises with the growth of the elderly population, the 
amount of patients with cognitive impairments will also increase. It will become imperative to 
reduce the burden of cognitive dysfunction associated with heart failure to allow for gains in 
survival rates, improvements in quality of life and reductions in resource consumption. The key 
to improving prevention lies in a better understanding of the underlying mechanisms. 
1.3 Cerebral Blood Flow in Heart Failure  
The main mechanistic link for the relationship between cognitive impairments and heart 
failure is believed to be reduced brain perfusion to hypoxia sensitive structures in the brain 
(Roman, 2004). Experimental evidence from animal models supports the link between reduced 
brain blood flow and cognitive decline (Ohta et al., 1997; De Jong et al., 1999). Chronic 
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reductions in cerebral blood flow (CBF) were induced by ligation of either the common or 
internal carotid arteries. Over time, the animals developed impairments in learning and memory 
directly related to the degree of neuronal disorganization and also developed changes to the 
capillaries that supply the neurons in the hippocampal region (De Jong et al., 1999; Ohta et al., 
1997). In humans, indirect evidence supplied by systemic perfusion studies and direct 
measurement of brain perfusion will be discussed in support of the hypoperfusion hypothesis. 
1.3.1 Indirect Evidence 
Cognitive decline in heart failure is believed to arise due to cardiac dysfunction altering 
systemic perfusion and consequently cerebral perfusion. Normally CBF is maintained by 
autoregulation, a process where despite changing cerebral perfusion pressure, blood flow to the 
brain is maintained via changes in vasomotor tone (Lassen, 1959). The integrity of cerebral 
autoregulation in heart failure has not been investigated but reports suggest that it is impaired 
with chronic systemic hypoperfusion (Tranmer et al., 1992), a hallmark of heart failure. In 
addition, cerebrovascular reactivity, a measure of reserve dilatory capacity, has been reported to 
be compromised in heart failure (Georgiadis et al., 2000). Therefore, the built in mechanisms 
responsible for maintaining blood flow to the brain in the face of impaired output from the heart 
may not be fully functional in heart failure. Furthermore, a low Q in heart failure may limit CBF 
(Saha et al., 1993). Thus, indices of systemic perfusion are of interest when studying the 
relationship between heart failure and cognitive functioning. Several studies have attempted to 
draw associations between cognitive test scores and LVEF as an index of cardiac function and 
systemic perfusion. Zuccalà and colleagues investigated the relationship between LVEF and 
cognitive state assessed by the mini mental state examination (MMSE) in an elderly heart failure 
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sample. The authors reported that when entered into an age and sex adjusted regression model, 
LVEF was significantly associated with MMSE score (Zuccala et al., 1997). Similarly, others 
have reported independent associations between cognitive functioning and LVEF (Hoth et al., 
2008; Festa et al., 2011; Almeida & Tamai, 2001) supporting the role of reduced CBF secondary 
to diminished systemic perfusion as a main contributor to neuropsychological impairment in 
heart failure. However, conflicting reports have also been published where no relationship has 
been found between systemic hypoperfusion measured by LVEF and cognition (Jefferson et al., 
2007a; Wolfe et al., 2006; Bornstein et al., 1995).  
The use of LVEF offers one explanation for these inconsistent findings. LVEF is a 
common clinical indicator of heart failure severity that is used to classify patients; however, it 
may not always provide accurate estimates (Jefferson et al., 2007a). Therefore Q is proposed in 
this thesis as an alternative measure of cardiac function and systemic perfusion as it quantifies 
the amount of blood flow leaving the ventricle into systemic circulation, measured in liters per 
minute (L/min). When LVEF and Q were compared within a patient sample over the age of 55 
with prevalent cardiovascular disease, patients with clinically normal LVEF had low Q values 
43% of the time. Furthermore, the two measurements were in agreement less than half the time 
(see Appendix A) (Jefferson, 2010). This finding supports the fact that the two measurements, Q 
and LVEF, are incompatible measures representing distinct parameters of cardiac function and Q 
may better represent systemic perfusion as it is free of the confounding factors that influence 
LVEF. When investigated as an indicator of systemic perfusion, evidence suggests that Q is 
associated with cognitive test scores and neuroimaging, although studies in this area remain 
scarce. In an aging cohort with stable CVD, low Q (<4.0 L/min) was related to impairments in 
neuropsychological tests, mainly in executive function, compared to normal Q (>4.0 L/min) 
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(Jefferson et al., 2007a). Additionally, CVD patients with a lower Q experience a faster rate of 
decline on an Attention-Executive-Psychomotor composite score when followed for 36 months 
(Okonkwo et al., 2011). Neuroimaging abnormalities have also been inversely linked to Q 
values. White matter hyperintensities (WMH) are areas of high intensity within the cerebral 
white matter of the brain that are made visible by a magnetic resonance imaging scan and are 
indicative of ischemia or lesions in that area (Fernando et al., 2006). They become increasingly 
prevalent with age and are associated with reduced mean flow velocity (MFV) and lower 
cognitive performance (de Groot et al., 2001; de Leeuw et al., 2001; Tzourio et al., 2001). As the 
result of work by Jefferson and colleagues, systemic blood flow measured by Q has also been 
found to be inversely associated with WMH’s independent of age and hypertension (Jefferson et 
al., 2007b).  When scaled to body surface area, Q has furthermore been correlated to systolic 
blood velocity through the middle cerebral artery (MCA) (Saha et al., 1993). Therefore, as an 
indicator of systemic perfusion, Q has been found to be associated with cognitive test scores, 
neuroimaging abnormalities and cerebral hemodynamics through the MCA. In spite of this, 
future studies are needed to elucidate the relationship in a heart failure cohort, Q values as a 
reflection of systemic perfusion may better identify those at risk for cerebral hypoperfusion and 
cognitive decline than LVEF. 
1.3.2 Direct Evidence 
In addition to the aforementioned indirect evidence suggesting cerebral hypoperfusion as 
the mechanistic link between heart failure and cognitive decline, CBF has also been directly 
measured using a variety of techniques. In 2006, Choi and colleagues found that resting supine 
global CBF, measured by radionuclide angiography, was reduced by 19% in advanced heart 
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failure compared to healthy controls (Choi et al., 2006). This finding has been duplicated in an 
elderly male sample (age 68 ± 7 years) where a 14% reduction was found through the utilization 
of ultrasound to quantify global supine CBF by summing bilateral internal and vertebral artery 
blood flow (Loncar et al., 2011). In both of these studies, the degree of CBF decline was related 
to the New York Heart Association (NYHA) functional class (Appendix B). Reductions, some as 
high as 30%, have also been reported by other researchers (Vogels et al., 2008; Gruhn et al., 
2001; Massaro et al., 2006). Cerebral hypoperfusion observed in hypertensive patients is 
strongly associated with later cognitive decline (Kitagawa, 2010) but in heart failure, 
investigations where neurological testing is performed in addition to CBF are scarce.  In one 
report, Alves and others report a direct correlation between cognitive scores and resting CBF 
values (Alves et al., 2005). In contrast, when MFV measured at the MCA was compared to a 
mean cognitive z-score in mild to moderate heart failure patients no correlation was reported 
(Vogels et al., 2008). It is possible that the use of MFV as a surrogate for CBF could partly 
explain the lack of relationship found in this study. Furthermore, reductions in CBF were mild so 
the specific sample in this study may have still been able to compensate through cerebral 
autoregulation mechanisms. Many observations provide strong arguments for the heart-brain 
connection and the cerebral hypoperfusion hypothesis for cognitive dysfunction. Findings from 
the Rotterdam study suggest that cerebral hypoperfusion precedes clinical onset dementia 
(Ruitenberg et al., 2005). When heart function is improved with transplantation or cardiac 
resynchronization therapy, CBF can be restored and cognition improvements have been noted 
(Gruhn et al., 2001; Dixit et al., 2010; van Bommel et al., 2010). These results suggest a role for 
heart dysfunction in cognitive decline which acts through cerebral hypoperfusion.  
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 All of the studies that have directly measured CBF have had an inclusion criterion of 
LVEF<50%. The average LVEF for the patients in these studies was 26.7 ± 7.67 %, therefore 
being inclusive to HFrEF. The relationship between HFpEF and cognitive decline has not yet 
received much attention because of the belief that since LVEF is preserved, output of blood to 
the rest of the body, including the brain, is also preserved. However, as previously mentioned, 
normal LVEF might not be a reliable indicator of normal Q. The definition of heart failure is the 
inability of the heart to pump sufficient blood to the rest of the body, identifying low Q as the 
main pathophysiologic abnormality (Libby et al., 2008). While depressed Q is a key element of 
the heart failure definition, it is rarely used in clinical practice. Although LVEF shows 
discrepancies between the two forms of heart failure, Q is the same if not lower in patients with 
HFpEF (Andrew, 2003). The previous discussion on Q as a predictor of cognitive decline, 
suggests that low Q is associated with irregular neuropsychological test scores and imaging. 
Therefore, even though LVEF is preserved, low Q values may also predispose this subset of the 
population to cognitive dysfunction. In CVD patients with normal LVEF, diastolic dysfunction 
was significantly correlated with cognitive impairment (Suwa & Ito, 2009). While resting CBF is 
well documented to be reduced in HFrEF it remains unknown whether the same is true for 
HFpEF and how this relates to cognitive state. Arterial stiffness, which is reported prevalent in 
this population subset, has been linked to lower CBF and may act as a contributor alongside the 
depressed Q (Robertson et al., 2010). A better understanding of cognition and CBF in both 
HFrEF and HFpEF will become increasingly important in the coming years with the rising 
prevalence and associated complications that contribute to significant morbidity and mortality. 
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1.4 Atrial Fibrillation, Cognition and Hypoperfusion 
Heart failure and atrial fibrillation have the tendency to co-exist as they share many risk 
factors but also because the existence of one may predispose you to the other (Wang et al., 
2003). The co-existence may render the brain more vulnerable to lower CBF and cognitive 
decline. In atrial fibrillation, the sinoatrial node does not trigger the atrial contractions resulting 
in uncoordinated, low voltage, high frequency depolarizations with no discernable P wave. With 
this condition, the rate of atrial contractions greatly exceeds that rate of ventricular contraction 
leading to improper ventricular filling and reduced Q (Daoud et al., 1996). The incidence of 
atrial fibrillation rises sharply with age and was estimated in 1997 to affect 6% of the Canadian 
population aged 65 years and older (Sacco et al., 1997). The Framingham heart study estimated 
the lifetime risk for atrial fibrillation to be 1 in 4 for men and women aged 40 years and older 
and 1 in 6 in the absence of heart failure or myocardial infarction (Lloyd-Jones et al., 2004). The 
Rotterdam study identified cognitive dysfunction as being twice as common in atrial fibrillation 
patients compared to those without atrial fibrillation (Ott et al., 1997). Stroke has been 
recognized as a major cause of cognitive impairment in atrial fibrillation (Mizrahi et al., 2011; 
Zhou et al., 2004). Atrial fibrillation increases the risk of ischemic stroke 5-fold (Wolf et al., 
1991). The increased risk is attributed mainly to the high occurrence of thromboembolic events 
that are the result of stagnant blood in the left atrium and left atrial appendage. In addition to 
ischemic strokes, thromboembolic events can also lead to silent strokes and transient ischemic 
attacks (TIAs); which both increase the risk of eventually having an ischemic stroke. Silent 
strokes, those present on CT scans but with no previous medical documentation, are prevalent in 
an estimated 15-26% of atrial fibrillation patients (Ezekowitz et al., 1995). Cognitive impairment 
in atrial fibrillation has been primarily attributed to thromboembolic events leading to ischemic 
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stroke with little focus on cerebral hypoperfusion. There are three ways in which cerebral 
hypoperfusion may be contributing to cognitive impairments in atrial fibrillation; two through 
stroke-dependent mechanisms and one through a stroke-independent mechanism. First, cerebral 
hypoperfusion may lead to hemodynamic TIA and stroke (stroke not caused by emboli). Second, 
hypoperfusion and embolic mechanisms may be linked, rather than being two separate entities. 
Cerebral hypoperfusion increases the quantity of arterial thromboemboli and reduces washout 
and clearance of emboli that have entered the vascular bed of the under perfused regions (Caplan 
& Hennerici, 1998). Last, cerebral hypoperfusion can lead to hypoxic brain damage resulting in 
cognitive impairments. This offers an explanation for studies that have detected cognitive 
impairments in atrial fibrillation patients with no clinical evidence of stroke (stoke-independent 
cognitive impairments) (Ott et al., 1997; Marzona et al., 2012). Cerebral hypoperfusion may be 
further exaggerated by underlying CVD, such as heart failure. A flow diagram depicting the 
potential pathways involved in atrial fibrillation related cognitive impairment is included in 
figure 1.1 
In spite of the potential importance of cerebral hypoperfusion, few studies have 
investigated CBF in atrial fibrillation. Petersen et al. found CBF improvement after cardioversion 
therapy suggesting impairment at baseline; however there was no comparison to a healthy 
control group before the therapy and the patients had atrial fibrillation for less than three months 
in duration (Petersen et al., 1989). In contrast, Porebska and colleagues compared MFV in 
controls versus those with paroxysmal (temporary) atrial fibrillation and found no difference, 
likely because patients with this form of atrial fibrillation have more efficient heart function 
(Porebska et al., 2007). In both of the aforementioned studies, patients did not have coexisting 
heart failure. Cerebral hypoperfusion might be even more pronounced in heart failure patients 
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with atrial fibrillation as heart failure alone is well-documented to be associated with a reduction 
in CBF. One study sought to identify factors associated with CBF in heart failure patients. Using 
a linear regression analysis, the researchers found atrial fibrillation to be a significant negative 
determinant of CBF (β= -0.445, p<0.01) (Choi et al., 2006). Further research is needed to 
confirm these findings. Another area requiring further investigation is the variability in Q and 
CBF that is associated with the beat-to-beat variability inherent to atrial fibrillation. While this 
relationship has been previously suggested, evidence has yet to be documented in the literature. 
The brain requires a continuous blood supply to maintain function and is particularly sensitive to 
pulsatile flow. High flow can penetrate and damage the microvascular bed while periods of low 
flow contribute to microvascular ischemia (Mitchell et al., 2011). Thus it is important to 
determine if the irregular HR in atrial fibrillation translates to variability in CBF which has the 
potential to cause damage and impair cognitive functions (added in Figure 1.1) 
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Figure 1.1 Flow chart of mechanisms leading to cognitive impairment in atrial 
fibrillation  
Atrial fibrillation is associated with cognitive impairments. This association is either independent or 
dependent on a clinical documented stroke. Most cognitive impairments in atrial fibrillation are 
attributed to ischemic strokes caused by thromboembolism. However cerebral hypoperfusion may also 
be an important issue as cognitive impairments are documented in the absence of a stroke. Dashed lines 
indicate that less research has been performed versus solid lines representing a lot of attention has been 
paid to this area. TIA—transient ischemic attack; CVD—cardiovascular disease 
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1.5 Normal Physiologic Response to Upright Posture 
            When assuming an upright posture from lying flat, several adjustments are required. In a 
supine position, gravitational forces are evenly distributed throughout the body. However, 
standing up creates pressure gradients due to gravity and blood pools in the abdomen and lower 
extremities resulting in a decreased venous return to the heart (Silverthorn, 2007). Consequently, 
less blood is in the ventricle for the next contraction and arterial blood pressure (ABP) falls due 
to reduced Q. Necessary adjustments include increases in HR and total peripheral resistance to 
restore Q and ABP (Perlmuter & Greenberg, 1996). These are achieved in the short-term 
primarily by the baroreceptor reflex. Arterial baroreceptors, located in the aortic arch and carotid 
sinus, are stretch-sensitive mechanoreceptors (Silverthorn, 2007). A fall in ABP and filling 
pressures during an upright posture is detected by a decreased stretch of the receptors that then 
relay this information to the cardiovascular control centre in the medulla resulting in alterations 
to the activation levels of the sympathetic and parasympathetic nervous systems. Vagal 
withdrawal from the parasympathetic nervous system acts first increasing HR. Sympathetic 
nervous system activation further augments HR, increases stroke volume (SV) and leads to 
vasoconstriction (Silverthorn, 2007; Klabunde, 2005). Together, these alterations lead to 
increased Q and total peripheral resistance and ultimately to restored ABP. Hormonal responses 
normally have little to do with the initial response to standing upright but they may have a more 
important role during prolonged orthostatic stress. The renin-angiotensin-aldosterone system 
(RAAS) is activated by low ABP which it acts to restore through vasoconstriction and water 
retention (Silverthorn, 2007). If these neurovascular and hormonal adjustments are inadequate, 
ABP cannot be brought back up and remains depressed while upright; this is referred to as 
orthostatic hypotension (Perlmuter & Greenberg, 1996). Guidelines define orthostatic 
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hypotension as a decrease in systolic blood pressure of at least 20mmHg and/or diastolic blood 
pressure of at least 10mmHg within the first three minutes of assuming an upright posture 
(Freeman et al., 2011). 
            In addition to the drop in ABP, orthostasis causes a reduction in CBF due to a 
documented fall in both the arterial partial pressure of carbon dioxide (PaCO2) and cerebral 
perfusion pressure (Edgell et al., 2012).  The cerebral circulation is very sensitive to changes in 
CO2, a potent vasodilator (Vavilala et al., 2002). PaCO2 decreases when upright resulting in 
cerebrovascular constriction and a subsequent reduction in CBF. Furthermore, cerebral perfusion 
pressure falls due to the drop in ABP at the level of the brain, contributing to the lessened CBF. 
However, CBF is quickly restored by cerebrovascular autoregulatory mechanisms. As mentioned 
earlier, this mechanism ensures stable CBF in the face of fluctuating ABP. This is achieved by 
changing the resistance of small cerebral arteries and arterioles accordingly, that is, the vessels 
constrict and resistance increases as ABP rises and dilate as ABP falls (Vavilala et al., 2002). 
When ABP approaches the lower limit of 50mmHg and the upper limit of 150mmHg these 
vasomotor adjustments become exhausted and cerebrovascular resistance cannot increase or 
decrease any further to regulate CBF (see Appendix C)(Panerai, 1998). Importantly, the 
autoregulatory limits can be altered during pathological states; for example, the upper and lower 
limits are shifted to higher values during chronic hypertension (Iadecola & Davisson, 2008). If 
ABP is inadequately restored during an orthostatic stress and falls beyond the lower limit then 
CBF becomes pressure-dependent and the homeostatic protection of cerebral autoregulation is 
lost, ultimately resulting in reduced CBF that can lead to syncope (Silverthorn, 2007).  
               Cerebral autoregulation can be assessed by methods that cause simultaneous changes in 
ABP and CBF; however no gold standard is available. A commonly used technique is bilateral 
 16 
 
thigh cuffs, which employs cuff inflation and subsequent deflation to induce significant and rapid 
changes in ABP (Aaslid et al., 1989). This method has been criticized for being painful and not 
representative of the physiological stresses of everyday life. Posture changes throughout the day 
threaten CBF and therefore a sit-to-stand method has been used to evaluate autoregulation for its 
realistic implications of daily living (Sorond et al., 2009; Lipsitz et al., 2000). The assessment of 
cerebral autoregulation is important because it may expose cerebrovascular abnormalities that 
only become apparent when the system is challenged. Additionally, it provides valuable clinical 
information by identifying those at risk for cerebral ischemia or secondary brain damage due to 
hypoperfusion or hyperperfusion, respectively (Panerai, 1998). To prevent these complications, 
the identified patients require tight control of fluctuating ABP so to avoid changes in CBF. 
1.6 Implications of Orthostatic Hypotension  
             The prevalence of orthostatic hypotension (OH) increases with advancing age (Rutan et 
al., 1992; Rose et al., 2000). However the prevalence reported in the literature varies greatly, 
from 5 to 30%, depending on the composition of the population being studied and the 
experimental conditions such as the time of day and the type of orthostatic test performed (Low, 
2008). Age-related physiological changes responsible for the higher prevalence of OH include 
vascular stiffening, decreased baroreflex sensitivity, reduced responsiveness to sympathetic 
stimulation and reduced parasympathetic tone (Benvenuto & Krakoff, 2011). Additionally, there 
are a number of risk factors for OH that accompany older age including dehydration, the number 
and type of medications prescribed, hypertension and diabetes (Benvenuto & Krakoff, 2011). 
Several longitudinal studies have been performed in order to determine if OH is a secondary by-
product phenomenon of other disease states or if it is a serious independent risk factor. These 
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investigations have uncovered that the presence of OH predicts future risk for CVD and overall 
mortality (Rose et al., 2000; Masaki et al., 1998; Verwoert et al., 2008).  
                  Interestingly, OH has also been found to be associated with cognitive dysfunction in 
an elderly cohort (age 76 ± 8 years) (Mehrabian et al., 2010). Cerebral hypoperfusion resulting 
from OH represents a mechanistic link to cognitive impairment. It can acutely affect many 
cognitive domains due to reduced delivery of nutrients and oxygen, and when repeated or 
sustained can cause more permanent damage, such as WMH, that are implicated in the 
pathogenesis of cognitive decline (de Groot et al., 2001; Tzourio et al., 2001). The cerebral 
circulation is challenged during orthostasis and thus cognitive deficits may become more 
pronounced in an upright position. Patient populations that are susceptible to OH and thus 
recurrent falls in ABP are at a high risk for this postural cognitive loss. For example, patients 
diagnosed with neurogenic OH had significantly worse global cognitive function and 
performance on specific tasks that mainly involved executive function during head up tilt 
compared to supine (Poda et al., 2012). However, this study was limited in that CBF was not 
assessed in the different postures or during the cognitive tests. Postural cognitive loss has also 
been studied in patients with chronic fatigue syndrome (CFS) which is associated distinctly with 
orthostatic intolerance and cognitive impairment (Stewart et al., 2012). Patients along with age- 
and sex-matched controls were tested supine and at five incremental tilt angles (15, 30, 45, 60 
and 75 degrees) while MFV was measured continuously with transcranial Doppler (TCD). An n-
back test (n=0 to 4) was administered in each tilt angle and required the participants to monitor a 
series of stimuli and respond when the stimulus was the same as the one presented n-trials 
previously. The number of correct responses and the reaction time progressively worsened for 
each n-back level as tilt angle increased from supine in the CFS patients while performance 
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remained the same in the control subjects (Stewart et al., 2012). Additionally, MFV decreased as 
tilt angle increased within each n-back level for CFS while MFV in controls was unaffected by 
orthostasis (Stewart et al., 2012). Taken together these results suggest that orthostatic stress can 
reveal neurocognitive impairment and reduced MFV in CFS subjects compared to control 
subjects. These studies unveil some important considerations. In clinical populations with OH, 
cognitive posture testing exposes impairments that are not apparent in the supine position. 
Postural cognitive loss is a significant problem as the majority of daily activities are not 
performed while supine. Therefore cognitive loss while upright may interfere with the ability to 
independently perform activities of daily living, highlighting the importance of early 
identification and treatment. 
1.7 Orthostasis in Heart Failure 
As described above, the baroreceptor reflex is an important mechanism for restoring ABP 
during an orthostatic challenge. Abnormalities in this reflex have been reported in heart failure 
through utilization of a neck chamber. By changing the pressure in the neck chamber inverse 
pressure changes are produced in the carotid arteries, thus stimulating or unloading the 
baroreceptors. Sopher and colleagues utilized this method and caused step-wise changes in 
pressure while simultaneously measuring HR at each step. They found that the sensitivity of the 
baroreceptor reflex was impaired in heart failure patients compared to controls (Sopher et al., 
1990). 
The fluid shifts and elevated peripheral resistance associated with moving to an upright 
posture result in decreased preload and increased afterload of the heart, respectively 
(Mehagnoul-Schipper et al., 2003). These changes mean there is less blood available for 
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pumping and increased work demands placed on the heart; both of which are less than ideal 
conditions for a failing heart and increase the likelihood of orthostatic cerebral symptoms. In 
1951, an initial report was published suggesting that individuals with heart failure respond 
irregularly to upright tilt (Howard & Leathart, 1951) , a finding that was investigated further in 
following studies. The increase in HR normally associated with upright posture is diminished in 
heart failure (Levine et al., 1983). Vasodilation occurring in the forearm and calf during 
orthostasis has been documented in contrast to the expected vasoconstriction (Wroblewski, 1994; 
Goldsmith et al., 1983a). Additionally, neurohumoral factors, such as norepinephrine, renin and 
arginine vasopressin are elevated at rest in heart failure but have attenuated increases in response 
to upright tilt (Goldsmith et al., 1983b; Levine et al., 1983). Due to this irregular orthostatic 
response, one would expect the prevalence of OH be higher in heart failure patients. In a group 
of elderly women, the diagnosis of OH was warranted in 83% of patients compared to 53% of 
controls (Potocka-Plazak & Plazak, 2001).  Additionally, symptomatic OH was not present in 
any controls but was present in 36% of heart failure patients which was likely related to the 
larger drop in systolic blood pressure and reduced ability to compensate with HR in this group 
(Potocka-Plazak & Plazak, 2001). In sum, heart failure patients typically respond abnormally to 
orthostatic challenges and have a higher prevalence of OH that is more likely to be symptomatic 
than age-matched controls.  
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2.0 Study Rationale 
Although a reduced resting CBF in heart failure is generally well-accepted, it is unknown 
how CBF is affected by daily challenges that threaten cerebral perfusion, such as upright posture. 
Since a large proportion of the day is spent vertical, investigating CBF in positions other than 
supine is highly relevant. If CBF is not maintained upright it can lead to hypoxic regions and 
ischemia resulting in a compromised cognitive status. Some heart failure patients experience 
orthostatic hypotension that can be attributed to a blunted HR or Q response and/or to a 
paradoxical vasodilation to peripheral vascular beds such as to the calf or forearm (Levine et al., 
1983; Goldsmith et al., 1983a; Wroblewski, 1994). This abnormal response to orthostasis can 
lead to decreased CBF and postural cognitive deficits. Thus, it is of interest to determine the CBF 
and cognitive response to upright positions in heart failure patients. 
Past studies have suggested the main pathophysiological link responsible for cognitive 
impairment in heart failure to be cerebral hypoperfusion (Loncar et al., 2011; Zuccala et al., 
1997). This relationship has primarily been investigated in heart failure patients who have a 
reduced LVEF since preserved LVEF patients are typically excluded from clinical studies. 
Badano et al. investigated the clinical characteristics of patients with chronic heart failure 
enrolled in clinical trials to those seen in the real world as characterized by epidemiology studies. 
Their results confirm that patients characterized by epidemiology research have an ejection 
fraction approximately 12% higher than patients enrolled in clinical trials (Badano et al., 2003). 
Furthermore, from the trials included in their analysis, 0% had an ejection fraction >40% 
compared to 34% real world patients existing in this subgroup (Appendix D). Since normal 
LVEF does not necessarily imply normal Q, this significant portion of the population may also 
have reduced CBF threatening cognitive status. Therefore we will include a spectrum of LVEF 
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to investigate whether LVEF is related to cognitive scores or CBF. Furthermore, Q will be 
investigated as a potentially better predictor of CBF. Since atrial fibrillation and heart failure 
frequently co-exist, we will investigate CBF in heart failure with coexisting atrial fibrillation, 
specifically to determine if the variability in HR that is innate to atrial fibrillation translates to Q 
and MFV variability. 
In sum, reduced Q and CBF have been reported in the supine position although it remains 
to be known how these variables respond to upright positions common to daily living. A lower 
upright CBF might further insult the low supine CBF and contribute to cognitive decline. 
Including a patient population that is representative to those seen in clinical practice is beneficial 
in the translation of research. Specifically, little information exists on cerebral hemodynamics for 
those with HFpEF or atrial fibrillation with coexisting heart failure. The following section 
outlines the specific objectives and hypotheses of this thesis. 
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3.0 Study Objectives and Hypotheses 
Primary Objectives 
1) Assess the influence of orthostatic stress on CBF in heart failure patients compared to a 
healthy age and sex-matched control population. 
2) Ascertain whether cognitive performance and cognitive-activated hemodynamics worsen 
in the upright position in heart failure 
Secondary Objectives 
3) Include a spectrum of LVEFs, from preserved to reduced, in the overall heart failure 
sample. Determine whether LVEF is correlated with CBF or cognitive scores. Further 
assess if Q is correlated with LVEF or CBF.  
4) Assess Q and MFV variability in heart failure patients who also have atrial fibrillation  
Hypotheses 
1) Seated CBF will be reduced compared to supine more so in the heart failure patients. 
2) Cognitive performance will be worse in the seated position compared to supine. The 
hemodynamic response to the cognitive task will be attenuated when seated compared to 
supine. 
3) LVEF will not be correlated with cognitive score, CBF or Q suggesting HFpEF will have 
similar hemodynamic and cognitive characteristics as HFrEF. Q will better predict CBF 
than LVEF.  
4) Q and MFV variability will be greater in patients with atrial fibrillation 
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4.0 Methods 
4.1 Ethics 
The experimental procedures for this study were approved by the Office of Research 
Ethics at the University of Waterloo (ORE #18543). All patients volunteered freely after reading 
and signing an information-consent form. They were aware of their rights to withdraw from the 
study at any time. 
4.2 Recruitment 
4.2.1 Heart Failure Patients 
Twenty-two independently-living, stable heart failure patients participated in this study 
between April 2013 and October 2013. Inclusion and exclusion criteria for this study are listed in 
Table 4.1. Recruited occurred at two family practices (New Vision family health care team and 
Dr. Jagas’ practice at the Frederick Street Medical Center), a cardiology clinic (Dr. Fowlis) in the 
Kitchener-Waterloo region and from the Heart Function Clinic at the Hamilton General Hospital. 
Patients were first approached about the study by a health care professional within the patient’s 
circle of care from each clinic. They were provided a short description of what the study entailed 
and asked if they would be willing to receive a phone call with more information. Thirty-two 
patients agreed to be contacted by phone. The reasons for exclusion and arrival at the final 
sample of twenty-two are presented in Figure 4.1. Data collection took place at the University of 
Waterloo (n=6) or on-site at one of the specified clinics (n=16) based on preference of the 
recruiting doctor and convenience for the patient. LVEF and NYHA class were performed by 
different medical professionals and were obtained from patient’s health record. The NYHA is an 
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index of severity and the breakdown of each class is included in Appendix B. A list of current 
medications was provided by the patient on the day of the testing.  
4.2.2 Controls 
 Fifteen heart failure patients were age- and sex-matched with healthy control subjects 
from a previously collected sample. In general, this sample was high-functioning older adults (≥ 
65 years old) that were recruited from the community. A detailed description of these 
participants can be found in Dr. A. Robertson’s thesis dissertation (Robertson, 2013). In order to 
match heart failure patients who were <65 years old, seven additional control subjects were 
collected from the community. Data collection techniques for all control subjects were the same 
as those described below. 
4.3 Experimental Protocol Overview 
When the heart failure patients first arrived for testing they read and signed the 
information-consent form. The protocol and equipment were described until they were 
comfortable and all questions and concerns were addressed. Additionally, they were encouraged 
to ask any further questions that arose as the test progressed. Following this initial familiarization 
and orientation, a global cognitive test (Montreal Cognitive Assessment-MoCA) was 
administered and the n-back test was explained and practiced. Two 8-meter timed walking tests 
were then completed. After obtaining height and weight measurements, the patients were assisted 
into a comfortable supine position on a bed, where they were instrumented with equipment for 
continuous beat-by-beat monitoring of HR, blood pressure and MFV and breath-by-breath 
monitoring of exhaled CO2. Once the patient had rested supine for 10 minutes and all signals 
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were optimized and stable, carotid pulse pressure (PPcar) was measured using applanation 
tonometry and right common carotid artery (CCA) and bilateral internal carotid artery (ICA) 
ultrasound imaging was performed. Patients then completed the n-back test in the supine position 
before being assisted to a seated position. Following a stabilization period in the sitting position 
of 5-10 minutes, a Q rebreathing trial was done followed by ultrasound imaging on the right 
ICA. A second rebreathing trial was completed and the n-back test was repeated while seated. 
Information about the rebreathing technique and results can be found in appendix E. Before 
leaving, hip and waist circumferences were measured half way between the top of the iliac crest 
and the lower rib and at the widest part of the buttocks, respectively. A questionnaire was 
described and distributed to be completed at home and mailed back in the pre-posted envelope. 
The test duration was between 1.5 and 2 hours depending on the ease of signal acquisition. A 
more in-depth description of each data collection technique discussed in this overview is 
included below. 
4.4 Data Collection 
4.4.1 Cognitive Testing 
Global cognition was assessed with the MoCA.  The MoCA is a rapid 30-item cognitive 
screening tool that takes approximately 10 minutes to administer and was developed as a tool 
sensitive enough to screen older adults who present with MCI (Nasreddine et al., 2005). It 
includes the assessment of eight different domains; attention and concentration, executive 
function, memory, language, visual/constructional skills, conceptual thinking, calculations and 
orientations (Harkness et al., 2011). A MoCA score of <26 out of a maximal possible score of 30 
warrants a diagnosis of MCI and further neurocognitive investigation. Although the MMSE is 
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frequently used to screen for dementia and track cognitive changes over time, it is not sensitive 
enough to detect subtle cognitive impairments. The MoCA has been increasingly used in the 
heart failure population and was applied in this study because it tests many of the cognitive 
domains most often affected by this disease and it is highly sensitive in detecting MCI compared 
to the MMSE in older patients with heart failure (Cameron et al., 2013; Harkness et al., 2011). 
 The n-back test is a frequently used instrument to measure working memory, attention 
and reaction time (Stewart et al., 2012). This test has the ability to be delivered rapidly and in an 
auditory fashion in a supine and seated position and therefore was chosen to assess cognition in 
these two positions. Additionally, the area of the brain activated by the n-back is supplied by the 
MCA which was monitored non-invasively and continuously using TCD (Stewart et al., 2012). 
The n-back test was administered through an audio computer program where the patients listened 
to a series of numbers and responded by clicking a trigger button in their right hand when the 
number was the same as the one presented n-trials previously. Two n-back levels were presented 
(n=1 and n=2) subsequent to a control 0-back condition where patients responded to a pre-
determined number. Patients became familiarized and practiced each n-back level with different, 
condensed number sequences prior to the start of data collection. All of the numbers consisted of 
two syllables with an interstimulus duration of one second and a ten second pause between each 
level. Different number sequences (total numbers=29) were used in each level with the potential 
for six correct responses per level. The number sequences also differed when receiving the test 
supine versus seated, which was randomized between patients. The numbers of correct responses 
as well as the reaction times were recorded for later analysis. 
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4.4.2 8-Meter Walk Test 
 An 8-meter walk test was performed to assess gait speed as a single indicator of frailty 
(Fried et al., 2001). Patients were instructed to walk at a normal pace as if they were walking 
down the street to the bank. If walking aids such as canes or walkers were required, they were 
used. Following a short count down, they started walking on the ‘go’ command. Timing was 
stopped at the 8-meter mark but patients continued walking past this point to prevent the time 
required to slow down and stop from influencing the timing outcome. 
4.4.3 Continuous Measurements 
Measures of ABP, HR, CO2 and MFV were collected continuously at 1kHz using data 
acquisition hardware (Powerlab, AD Instruments, Colorado Springs, CO, USA) and recorded to 
a computer using associated software (Chart v.5.5.6, AD Instruments) for later analysis.  
ABP was measured by sphygmomanometry in the supine and seated position then beat-
by-beat throughout the test using finger-cuff plethysmography (Finometer Pro, Finapres Medical 
Systems, Amsterdam, the Netherlands). In this technique the finger is wrapped with an inflatable 
cuff that uses infrared plethysmography to monitor and adjust the cuff pressure to the arterial 
finger pressure during each heartbeat. Internal corrections then adjust the shape and amplitude of 
the finger pressure waveform to that of the brachial waveform. This correction is supported by 
accounting for the vertical height difference between the finger and heart that is measured by a 
fluid filled tube attached to the finger cuff which travels to a pressure transducer secured at heart 
level. A brachial cuff calibration before data collection further validates the finger pressure as a 
representation of blood pressure at heart level.  
 28 
 
Electrocardiography was recorded beat-by-beat and the R-R intervals were later used for 
the determination of HR (ECG module, Finapres Medical Systems, Amsterdam, the 
Netherlands).  
Breath-by-breath exhaled CO2 was sampled through a nasal cannula and analyzed by 
infrared spectroscopy (Ohmeda 5200 CO2 Monitor, Madison, WI).  
MFV from the MCA (MFVMCA) was collected beat-by-beat using TCD. A 2MHz 
transducer (Neurovision Transcranial Doppler System Model 500M, Multigon Industries Inc., 
Yonkers, NY, USA) was placed over the right temporal window with a slight forward orientation 
to track the sphenoidal segment (M1) of the MCA, which runs horizontally from nose to ear. The 
temporal window is the thinnest portion of the temporal bone that allows for the vessels of the 
circle of Willis to be exposed to ultrasound. Insonation of the MCA was confirmed with the 
velocity profile, strength of the signal, auditory pitch, signal depth and probe angle. The outer 
envelope of the power spectrum from the MCA was recorded for later analysis. An adjustable 
headpiece was used to hold the transducer in place (Marc 600, Spencer Technologies, Seattle, 
WA USA) to ensure stable probe positioning across the different postures. 
4.4.4 Applanation Tonometry 
 Applanation tonometry (SPT-301, Millar Instruments, Houston TX USA) was used to 
measure the pulse pressure in the CCA (PPcar). Once the blood pressure reading from the 
Finometer had stabilized, the tonometer was held to the left CCA for 20-30 consecutive cardiac 
cycles. The tonometer was calibrated using a two-point calibration with the mean and diastolic 
brachial pressures as there is <3mmHg difference in these measures between the two sites 
(O'Rourke et al., 2001).   
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4.4.5 Ultrasound 
While TCD measures blood velocity, it is commonly used as an index of flow under the 
assumption that the diameter of the MCA remains constant. Studies have been conducted to 
verify an unchanging MCA diameter (Serrador et al., 2000) however others have reported 
changing diameter under extreme conditions (Valdueza et al., 1999). Furthermore, in this study 
population, variation in diameters due to sex or genetic differences, age and/or atherosclerosis 
between subjects will almost certainly influence individual CBF values therefore limiting the 
between subject comparison. With the inability to determine MCA diameter, TCD will be used 
to indicate MFVMCA and not CBF. While it is not appropriate for TCD to be used as an absolute 
indicator of CBF, it can help determine changes over time in MFVMCA, which in the absence of 
changes in conditions can reflect changes in CBF within a person. In this study, CBF was 
quantified by measuring bilateral ICA using ultrasound while supine. To investigate the change 
in CBF when upright, the right ICA was measured while seated. An 8-12 MHz linear array 
transducer (L14-6s with M5 system, Mindray, Shenzhen, China) was used to image the ICA 
diameter 1-2cm distal to the carotid bifurcation while the Doppler function of the same probe 
permitted measurement of MFV of the ICA (MFVICA). To obtain a measure of intima media 
thickness (IMT), the walls of the right CCA were imaged supine. 
4.4.6 Cardiac Output 
 There were two ways in which Q was obtained for this thesis: estimated from the 
Finometer device (Q_Fin) and measured directly with a foreign gas rebreathing method (Q_Inn) 
(Appendix E). The Q_Fin estimate makes use of an internal algorithm. The algorithm uses the 
finger arterial pressure waveform as well as the age and sex of the patient to estimate the aortic 
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flow waveform. The shape of the aortic waveform is then used to calculate SV and subsequently 
Q. The benefit of this method is that is gives an estimate of Q, non-invasively, with each heart 
beat. However, variables are not directly measured and some have questioned its accuracy in 
providing absolute values (Azabji et al., 2004).  
4.4.7 Take-home Questionnaire 
 Patients were given a questionnaire to fill out at home and mail back to the University in 
a pre-posted envelope (see Appendix F). They were asked questions regarding their cultural 
background, marital status, education and previous work experiences. Sleep and physical activity 
patterns along with smoking and alcohol use were also questioned. Lastly, the Geriatric 
Depression Scale short form (GDS-SF) was included at the end of the questionnaire which is a 
self-reported 15 item questionnaire to be used specifically on older adults where patients answer 
“yes” or “no” to each question. The GDS-SF has been validated against the 30-question GDS for 
the evaluation of depressive symptoms (Sheikh JI & Yesavage JA, 1986).  
4.5 Data Analysis 
4.5.1 Anthropometric Calculations 
Waist to hip ratio (WHR) was calculated as the ratio of the circumference of the waist to 
that of the hips. WHR has been used as a measure of health as those with ‘apple-shaped’ bodies 
who carry more weight around the waist are at increased risk for health risks whereas those with 
‘pear-shaped’ bodies with more weight around the hips are at a lower risk. 
WHR= waist/hip 
Equation 4.1 Waist-Hip Ratio 
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Body mass index (BMI) is a measure of body size based on height and weight. 
BMI (kg/m
2
) = mass (kg) / (height(m))
2 
Equation 4.2 Body Mass Index 
Body surface area (BSA) is a calculated surface area of the human body. The Dubois and 
Dubois formula for the calculation of BSA was used (Du Bois & Du Bois, 1989). Due to the 
variations in body size between participants and between groups (heart failure and control), BSA 
was used to correct for volume measures, SV and Q (see below). 
BSA (m
2
) = 0.007184 * w(kg)
0.425
 * ht(cm)
0.725
 
Equation 4.3 Body Surface Area 
4.5.2 Cardiovascular Variable Calculations 
The continuous blood pressure tracing from the Finometer was compared to traditional 
manual sphygmomanometer measurements. When the Finometer brachial artery pressure 
differed from the manual sphygmomanometer method by >5mmHg, the Finometer values were 
corrected for by using the manual blood pressure values.  
Beat-by-beat SV and total peripheral resistance (TPR) were calculated with the following 
formulas: 
SV (mL/beat) = Q (L/min) / HR (bpm)*1000 
Equation 4.4 Stroke Volume 
TPR (mmHg/L/min) = MAP (mmHg) / Q (L/min) 
Equation 4.5 Total Peripheral Resistance 
As mentioned previously, Q and SV were corrected for body size by dividing by the 
calculated BSA for the individual. The resulting variables are cardiac index (Qi) and stroke 
volume index (SVi) and are reported for the remainder of this thesis. 
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4.5.3 Carbon Dioxide 
Breath-by-breath values for end-tidal CO2 concentration were obtained and time-matched 
to the beat-by-beat data for analysis. The maximum % CO2 concentration from each breath was 
identified on the capnographic output and then used in the conversion to end-tidal PCO2 (ETCO2) 
with units of mmHg. ETCO2 values were obtained by using ambient temperature and barometric 
pressure to convert the recorded percent CO2 values to mmHg. 
4.5.4 Transcranial Doppler 
TCD monitoring of the MFVMCA was successful in 18 of the 22 heart failure patients and 
22 of the 22 control subjects. Traditionally, TCD is limited in about 25% of older adults because 
of anatomical limitations, notably, with age, the structure of the temporal bone changes and the 
ultrasound signal cannot return to the transducer (Itoh et al., 1993). TCD is beneficial in that its 
temporal resolution (10-100Hz) allows for examination of blood flow and resistance index 
calculations within a cardiac cycle. Cerebrovascular resistance at the level of the MCA was 
examined using three indices. Cerebrovascular resistance index (CVRi) is calculated by the 
rearrangement of Ohm’s law (equation 4.6). Describing flow using this relationship is associated 
with a few assumptions: flow is assumed constant and laminar (Rowell, 1993), intracranial 
pressure (ICP) is constant and close to zero (Aaslid et al., 1989) and the drop in ABP with 
posture change is dominant to ICP fluctuations (Hughson et al., 2001). By rearranging equation 
4.6 and applying appropriate local factors we can calculate CVRi (equation 4.7). Of note, ABP 
must be corrected to brain level to account for the orthostatic pressure gradient between the brain 
and the heart when in an upright posture (distance (cm) - 0.78mmHg/cm).   Within a single 
cardiac cycle the systolic (SFV) and diastolic (DFV) flow velocities were  isolated lending to the 
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calculation of a pulsatility index (PI) and resistance index (RI) (equation 4.8 and 4.9, 
respectively). 
CBF= (ABP-ICP)/resistance 
Equation 4.6 Ohm’s Law for Cerebrovascular Circulation 
CVRi= ABPbrain/MFV 
Equation 4.7 Cerebrovascular Resistance Index 
PI= (systolic velocity-diastolic velocity)/ MFV 
Equation 4.8 Pulsatility Index 
RI= (systolic velocity-diastolic velocity)/ systolic velocity 
Equation 4.9 Resistance Index 
4.5.5 Supine and Seated Averages of Continuous Variables 
Once hemodynamic variables were stabilized and optimized supine and seated, a minute 
average was calculated for all of the continuous variables.  
4.5.6 Brachial and Carotid Pulse Pressure 
Brachial pulse pressure (PPbrach) provides an estimate of peripheral artery stiffness and 
was calculated by subtracting diastolic blood pressure from systolic blood pressure. The arterial 
pulse in more distal muscular arteries, such as the brachial, is influenced less by relative 
increases in stiffness in comparison to more central elastic arteries (O'Rourke & Hashimoto, 
2008). Thus, the PPcar in a more central elastic artery was examined using applanation tonometry 
as previously discussed. Once calibrated, PPcar was calculated in the same way as PPbrach. 
4.5.7 Ultrasound Analysis 
ICA diameter was measured during the diastolic phase by electronic calipers in triplicate 
and MFV was time-averaged using the Doppler function of the same probe. A peak SFV above 
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125cm/s is recognized as a good indicator of significant (>50%) narrowing of the ICA (Polak, 
2004); all peak SFV were <125 cm/s in this patient sample. CBF through each vessel (RICA and 
LICA) was computed from the diastolic diameter and time-averaged MFV (Equation 4.9). ICA 
flow was measured at least 1 cm distal to the carotid bifurcation to minimize the influence of 
turbulent flow in the carotid bulb. Global anterior CBF (aCBF) was estimated as the sum of 
bilateral ICA flow in the supine position.  
CBF = MFV∙π∙diameter2/4 
Equation 4.10 Cerebral Blood Flow 
IMT was computed on frozen longitudinal right CCA images during diastole. Eight 
distinct sets of electronic calipers were placed at the intima and media of the far walls. The 
calipers were equally distributed over a vessel segment of approximately 1cm in length and mean 
values were calculated (IMTmean).  
4.5.8 Cognitive Tests 
MoCA 
Formal educational achievements of ≤ 12 years were corrected for by providing an extra 
point to the overall MoCA score. The six individual cognitive domains present in the MoCA 
were isolated and a score was determined for each. The domains are: short-term memory, 
visuospatial function, executive function, attention, concentration and working memory, 
language and orientation. 
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N-back Outcomes 
The number of omissions and number of commissions were calculated for each n-back 
level. Omissions refer to the number of times the patient didn’t correctly respond and 
commissions are the number incorrect responses. Reaction times for incorrect responses were not 
included in the analysis. Accuracy was calculated based on a previously reported algorithm and 
is shown in equation 4.10 (Miller et al., 2009).  
Accuracy (%) = [1-((number of commissions +number of omissions)/total possible correct)] 
*100 
Equation 4.11 Response Accuracy 
N-back Hemodynamics 
In order to investigate how the cognitive task influenced hemodynamics in supine and 
seated positions, a baseline 1-min average was taken immediately before the start of the n-back 
test for all of the continuous collected and calculated variables. The same variables were then 
averaged for each n-back level and the change relative to the baseline value was calculated for 
each level supine and seated within the heart failure sample.  
4.5.9 Self-reported Variables 
Two heart failure patients did not return the questionnaire in the mail and physical 
activity questionnaire data were missing for one control subject. A score of >5 on the GDS was 
suggestive of depression. Scoring for the GDS and self-reported physical activity are included in 
appendix G and appendix H, respectively. 
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4.5.10 Atrial Fibrillation 
There were four heart failure patients who were identified as having atrial fibrillation by 
their medical charts and this was confirmed by the electrocardiogram. These four patients were 
then age and sex matched to heart failure patients without any evidence of atrial fibrillation. The 
standard deviation from each patient’s one minute supine average was calculated and then 
averaged for each group. 
4.6 Statistical Analysis 
The comparisons between heart failure and control characteristics were conducted using 
the non-parametric Mann-Whitney Rank Sum tests for continuous variables and z-tests for 
categorical variables. To investigate the various cognitive domain sub-scores between heart 
failure patients with normal and abnormal MoCA scores, Mann-Whitney Rank Sum tests were 
also used. The same statistical test investigated supine, seated and delta differences between 
control and heart failure patients. The outcome measures for the n-back were evaluated with 
Friedman repeated measures ANOVA on Ranks and a Tukey post-hoc test was used to isolate 
where the differences occurred.  Supine and seated differences for n-back hemodynamic delta’s 
from baseline to cognitive tasks were assessed with Signed Rank tests in each level (0, 1 and 2 
back). Spearman correlations (rs) were used to assess relationships between variables. Due to the 
fact that statistical significance depends heavily on sample size, effect sizes were calculated to 
determine the size of effect in the atrial fibrillation group versus the heart failure group with no 
atrial fibrillation. Glass’s ∆ effect size calculations were performed on the average standard 
deviations for Qi_Fin and MFVMCA (Ellis, 2009). Sample size calculations were also performed 
on these variables. Categorical variables are represented as frequency (%) and continuous 
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variables are represented as median (interquartile range). Statistical tests were considered 
statistically significant at p ≤ 0.05. Due to the small sample statistical trends were also reported 
at p ≤ 0.10. Data were analyzed using SigmaStat 11.0 (Systat Software Inc., Chicago, IL).   
 The decision to use nonparametric tests was made due to the fact that the assumptions of 
normality and equal variance for parametric tests were not being met for most variables. The 
sample size in this study is small and we believe a more conservative approach of non-
parametric statistics in these early stages is warranted.  
4.7 Methodological Considerations 
TCD was monitored unilaterally, on the right side only. Assumptions were made about 
bilateral symmetry. Similar assumptions were made about the IMT, and the change in ICA flow 
with posture. In a young, healthy population TCD on the left and right sides were found to be 
highly correlated; however, these results cannot be assumed to translate to the population in this 
study (Schmidt et al., 2003). To address this assumption bilateral ICA CBF was compared 
supine (see section 5.2.1) and no differences were found. Only the right ICA was measured 
seated and because supine values were the same it is presumed the change to this upright position 
is also the same.  
It should also be considered that the positions were not randomized; participants always 
began in the supine position and moved to the seated position second. With this in mind, results 
from the n-back test should be interpreted cautiously. Despite practicing the n-back before the 
test began, it is still possible that learning influenced cognitive outcomes in the seated position. 
Common symptoms reported by the heart failure patients in this study were fatigue, weakness 
and pain. While extreme attention was taken during testing to ensure patient comfort and 
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awareness of time it should still be considered that seated blood pressure may have been 
influenced by discomfort and/or fatigue.  
Also, posterior CBF through the vertebral arteries (VA) was not collected for this study. 
Vertebral arteries contribute about 25% to global CBF at rest. However, Loncar and colleagues 
reported no differences in VA flow between healthy subjects and heart failure patients (Loncar et 
al., 2011). Additionally, VA flow is well maintained in response to an orthostatic stress in young 
healthy subjects (Sato et al., 2012).  
 The accuracy of the Finometer has been reported by some (Raamat et al., 2006), but 
others have questioned its ability to provide reliable values in special populations or when a 
stress is applied (Stok et al., 2006; Azabji et al., 2004). A high level of vasoconstriction, such as 
when sympathetic activity is elevated, decreases the accuracy of the measurement (Raamat et al., 
2000). Further, stiffer arteries are accompanied by a smaller change in arterial cross-sectional 
area. This change in the pressure-diameter relationship can result in less accurate readings 
(Langewouters et al., 1986). Elevated sympathetic nervous system activity and arterial stiffness 
are both commonly associated with heart failure. This raises questions about the reliability of the 
Finometer results in the current study. Using the Finometer for non-invasive monitoring of 
cardiovascular variables in heart failure sample requires further examination. 
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Inclusion criteria Exclusion criteria 
 No recent major changes to medical regime  
 No history of myocardial infarction within 
the past 1 month 
 
 Transplant recipients 
 NYHA functional class IV 
 Hospital admission that required an 
overnight stay within the past 1 month 
 Stroke in the past 10 years 
 Known significant ICA stenosis >50%  
 Uncontrolled hypertension (≥ 160/90) 
 Documented diagnosis of dementia  
 Uncontrolled sleep apnea 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 4.1 Heart failure patient inclusion/ exclusion criteria 
NYHA—New York heart association 
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32 patients 
contacted by phone 
2 patients declined to 
participate (6%) 
5 patients were 
unable to be reached 
by phone (16%) 
3 patients cancelled 
prior to their 
scheduled test (9%) 
22 patients included 
in final sample (69%) 
Figure 4.1 Heart failure patient recruitment 
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5.0 Results 
5.1 Characteristics 
The characteristics of the 22 heart failure patients and 22 age- and sex-matched healthy 
controls are presented in Table 5.1 and medical characteristics in Table 5.2; all patients and 
controls were community-dwelling. There was a trend for heart failure patients to have a larger 
BMI (p=0.062) than controls, but no other differences were detected statistically for height, 
weight or WHR. Heart failure patients had higher scores on the GDS (p<0.001). Three heart 
failure patients and one control subject scored >5 on the GDS. Heart failure patients also had a 
slower gait speed (p<0.001), had lower scores on the MoCA (p<0.001), had a lower education 
(p<0.001), and a higher history of smoking (p<0.001). With regards to the medical 
characteristics, a higher proportion of heart failure group had a pacemaker or implanted cardiac 
defibrillator (ICD) (p<0.001) and diabetes (p=0.001) than the control group. Heart failure 
patients were more likely to be on the following medications: β-blockers (p<0.001), ACE-
inhibitors (p<0.001), Diuretics (p<0.001), Statins (p=0.015) and Plavix (p=0.013). There was a 
trend for Warfarin (p=0.055) to be higher in the heart failure group. Three heart failure patients 
were on anti-depressants (one person was on two). 
The NYHA class and LVEF of each heart failure patient are listed in Table 5.3. The 
average LVEF for the study sample was 33 ± 11%. Four patients had an LVEF of >45%. The 
NYHA classification breakdown was: 18% NYHA I-II, 55% NYHA II, 9% NYHA II-III and 
18% NYHA III.  
Physical activity levels as determined from the self-reported questionnaire are presented 
in Table 5.4. There was a trend for a greater proportion of the heart failure sample to be 
 42 
 
sedentary (55%) compared to their control counterparts (24%) (p=0.087). The proportion of 
control participants who were highly active (43%) was significantly different from the heart 
failure patients (5%) (p=0.014).  
Mild or moderate cognitive impairment (MoCA<26) was observed in 64% of heart 
failure patients, with no score <19. Comparisons in sub-scores for various cognitive domains 
between patients with normal and abnormal MoCA scores are presented in Table 5.5. There was 
no age difference between patients with normal and versus abnormal MoCA scores. Cognitive 
domains showing significant differences in sub-scores are short term memory (p=0.001), 
visuospatial function (p=0.002), executive function (p=0.025) and language (p=0.011). 
5.2 Posture Influence on Hemodynamics 
5.2.1 Supine 
The supine cardiovascular and cerebrovascular variables for heart failure and control 
groups are presented in Figures 5.1 and 5.2, with statistical comparisons in Table 5.6.  While HR, 
mean arterial pressure (MAP) and TPR were not different between groups, Qi_Fin (p<0.001) and 
SVi (p<0.001) were significantly lower in the heart failure patients. No differences were detected 
in MFVMCA, SFVMCA or CVRi, although DFVMCA was lower (p=0.026) and RI (p=0.001) and PI 
(p=0.001) were higher in the heart failure patients. The CBF through the LICA and RICA were 
compared within heart failure (243 mL/min versus 269 mL/min) and within controls (293 
mL/min versus 296 mL/min) and no differences were detected in either group (p=0.451 and 
p=0.872, respectively). Total blood flow through the right plus left ICA (aCBF) was lower 
(p=0.013) in heart failure (479 mL/min) compared to controls (627 mL/min). No differences 
between groups were detected in ETCO2. A trend was detected for PPcar to be higher in heart 
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failure versus controls (p=0.065) and no differences were found for PPbrach. The IMTmean was 
higher in heart failure (p=0.009). 
5.2.2 Seated 
The seated cardiovascular and cerebrovascular variables for heart failure and control 
groups are presented in Figures 5.1 and 5.2, with statistical comparisons in Table 5.7. Similar to 
the supine position, Qi_Fin (p<0.001) and SVi (p<0.001) were significantly lower in the heart 
failure group. There were no differences in MFVMCA or SFVMCA but DFVMCA was significantly 
lower in heart failure (p=0.003). Additionally in this group, RI (p<0.001) and PI (p<0.001) were 
higher compared to the control group. In the seated position, CBF through the RICA was lower 
in heart failure patients compared to the control group (p=0.003). No differences in any other 
variables were detected. 
5.2.3 Change from Supine to Seated (Deltas) 
 The cardiovascular responses to the change in posture for heart failure patients and 
controls are depicted in Figure 5.3. The heart failure group did not increase their HR and it 
actually decreased slightly (-0.4 bpm) from supine to seated in comparison to the control group 
who increased by 4 bpm (p=0.001). The decrease in SVi and Qi_Fin and increase in TPR from 
supine to seated was not significantly different between the groups. The change in MAP was not 
different. 
Figure 5.4 illustrates the cerebrovascular responses to the change in posture for the heart 
failure and the control group. The MFVMCA, SFVMCA (not shown) and CVRi decreased similarly 
from supine to seated for the controls and heart failure patients. DFVMCA decreased more in the 
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heart failure group (controls= -2.1cm/s; heart failure= -3.2cm/s), although this difference did not 
reach significance (p=0.090).  The increase in RI was not different; although PI increased 
significantly more in the heart failure group (p=0.018). Heart failure patients had a significantly 
greater decrease in CBFRICA (-29 mL/min) from supine to seated (p=0.001) compared to controls 
(-7 mL/min). The ETCO2 decreased supine to seated but was not different between heart failure 
and control.  
Appendix I shows the mean and standard deviation of the change in Qi_Fin and CBFRICA 
from supine to seated for healthy controls and heart failure patients. Due to the small sample in 
this study along with normality and equal variance assumptions being violated, non-parametric 
tests were applied and median (interquartile range) values are reported. Inherent differences 
between median and mean values account for a divergence in the Qi change from supine to 
seated. The mean Qi_Fin value (Appendix I) and individual responses (Figure 5.1) suggest that 
the Qi_Fin decrease from supine to seated may be more pronounced in heart failure.  
5.3 Postural N-back Outcomes and Hemodynamics in Heart Failure 
5.3.1 Cognitive Outcome Measures 
 The 0-back and 1-back were completed by 21 heart failure patients supine and seated 
whereas only 10 patients completed the 2-back in each posture. Healthy control subjects did not 
complete this test. The average age of patients who completed the first two levels was 68.7 ± 9.2 
years and 64.6 ± 8.8 years for those who completed all three levels. There were no differences in 
omissions, commissions, accuracy or reaction time when the first two levels were considered 
together (Table 5.8). Similar results were found when considering all three levels together (Table 
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5.9) except that accuracy decreased with the 2-back (p<0.001) in each posture with no 
differences between posture.  
5.3.2 Change in Hemodynamics from Baseline to Cognitive Load 
 Figure 5.5 illustrates the change in MFVMCA and MAP from baseline to the cognitive task 
for heart failure patients within the supine and seated positions for each cognitive load (0-back, 
1-back and 2-back). The increase in MFV was significantly lower when seated for all levels (0-
back p<0.001; 1-back p<0.001; 2-back p=0.014). There was also a trend for MAP to increase 
less in the seated position for the 1-back (p=0.056) and 2-back (p=0.064). The HR increase to the 
cognitive load tended to be lower seated in the 0-back (p=0.082), was significantly lower in the 
1-back (p=0.004) and was not different in the 2-back (p=0.193). It should be noted that the 
changes in HR were small, even when reaching statistical significance. The changes in the 
remaining variables between postures were not different within each cognitive load. Since these 
variables are not shown graphically, the p-values are listed in Table 5.10. 
5.4 Correlations 
Figure 5.6 illustrates the relationship between age and aCBF in the heart failure sample. 
A moderate negative correlation was statistically detected (p=0.017), in that, greater age was 
associated with a lower aCBF (rs=-0.58). However, there was no correlation between age and 
global cognition assessed by the MoCA (Figure 5.7; rs=-0.18, p=0.423). 
 Four patients with HFpEF were included in this study; due to the small sample LVEF 
will be presented as a continuum rather than separating the subtypes of heart failure. The LVEF 
relationship to Qi_Fin, MoCA and aCBF are shown in Figure 5.8, 5.9 and 5.10, respectively. 
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Importantly, higher LVEF that typically define HFpEF patients are not commonly included in 
these types of associations. No significant correlation was found between LVEF and supine 
Qi_Fin (rs=0.04, p=0.848). A low-moderate negative relationship was found between LVEF and 
MoCA score (rs= -0.30) but was not statistically significant (p=0.240) and no correlation was 
found between LVEF and supine aCBF (rs= 0.06, p= 0.805). A significant positive correlation 
was found between supine Qi_Fin and aCBF (rs=0.50, p=0.047) and is shown in Figure 5.11.  
5.5 Atrial Fibrillation 
 Characteristics of matched heart failure patients to those with heart failure and atrial 
fibrillation are shown in Table 5.11 and medical characteristics in Figure 5.12. Of note, the 
patients with heart failure and atrial fibrillation appear to have scored lower on the MoCA. 
Additionally, three of the four patients had HFpEF according to a LVEF cut-off of ≥45% that has 
been used in previous clinical trials (Carson et al., 2005). No patients with heart failure or heart 
failure and atrial fibrillation had a documented history of stroke. A beat-by-beat sample output 
from one individual heart failure patient (A) and heart failure patient with atrial fibrillation (B) is 
included in Figure 5.12. The atrial fibrillation in patient B is evident in the ECG tracing and the 
irregular HR results in subsequent variation in the ABP, MFVMCA and Qi channels. 
Hemodynamic averages and variability (average standard deviations) are presented in table 5.13. 
Effect size calculations on the variation of Qi and MFVMCA were performed and the results were 
1.93 and 1.13, respectively. These effect sizes are considered large by Cohen’s classification 
system (Cohen, 1962) suggesting statistical significance can be detected with a larger sample. 
Sample size calculations suggest statistical significance can already be detected with the sample 
of four for Qi variability and ten patients in each group would be required to detect significance 
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in the variation of MFVMCA. Figure 5.13 shows the ICA MFV tracing from one representative 
heart failure patient (A) and one heart failure patient with atrial fibrillation (note: same patients 
illustrated in figure 5.12). While the MFV through the right ICA is lower in the patient with 
atrial fibrillation, the diameter of the vessel is larger resulting in these particular patients having a 
comparable CBF through the right ICA (325 mL/min vs. 322 mL/min). An additional example 
comparing ICA flows is presented in Appendix J. The average MFVMCA that is listed in Table 
5.13 is lower in the atrial fibrillation group (49 cm/s versus 56 cm/s) but, as previously 
discussed, we are unable to determine the diameter of this vessel with this technique. The 
CBFRICA for healthy controls was 296mL/min, compared to the four-matched heart failure and 
heart failure with atrial fibrillation patients, 262mL/min and 246mL/min respectively 
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 Control 
n=22 
Heart Failure 
n=22 
Age (years) 68 (64-77) 68 (63-78) 
Sex males n(%) 18 (82) 18 (82) 
Height (cm) 172 (168-177) 171 (165-182) 
Weight (kg) 75 (73-84) 86 (73-94) 
BMI (kg/m2) 25 (23-28) 28 (25-32)# 
Waist/hip ratio 0.93 (0.84-0.96) 0.97 (0.87-1.0) 
GDS score 0 (0-1) 2.0 (1.5-3.5)* 
Gait speed (m/s) 1.28 (1.20-1.50) 0.97 (0.91-1.13)* 
MoCA score 28.5 (27.0-29.0) 24.5 (22.0-27.0)* 
Education (years) 17 (15-18) 12 (10-14)* 
History of smoking n(%) 4 (18) 17 (77)* 
 
 
 
 
 
 
 
Table 5.1 Patient characteristics 
All values are median (interquartile range); *p<0.001; #p<0.10. BMI—body mass index; GDS—
geriatric depression scale; MoCA—Montreal cognitive assessment. n=22 except for GDS- 
heart failure n=20; history of smoking- heart failure n= 20 
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 Control  Heart Failure 
Pacemaker/ICD 0 (0) 12 (54)* 
Diabetes  0 (0) 10 (45)* 
β-blocker  2 (9) 22 (100)* 
ACE-inhibitor  0 (0) 13 (59)* 
Diuretic  4 (18) 20 (91)* 
ANGII receptor antagonist  3 (14) 7 (32) 
Ca+2  channel blocker  0 (0) 3 (14) 
Nitroglycerin spray  0 (0) 4 (18) 
Statin  7 (32) 16 (73)* 
Alpha-1 antagonist 3 (14) 4 (18) 
Aspirin 4 (18) 7 (32) 
Warfarin 1 (5) 7 (32)# 
Plavix 0 (0) 7 (32)* 
Antidepressant 0 (0) 4 (18) 
 
 
 
 
 
 
 
 
Table 5.2 Medical characteristics 
All values are n (%); *p<0.05; #p<0.10 
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Patient LVEF (%) NYHA class 
1 25-30 II 
2 <40 II 
3 25 III 
4 23-27 II 
5 40 I-II 
6 25-30 II-III 
7 38 III 
8 40 II 
9 55 I-II 
10 55 I-II 
11 25 I-II 
12 20 II 
13 27 II 
14 24 II 
15 35-40 II 
16 30 II 
17 25 II 
18 45 II 
19 30-32 III 
20 56 III 
21 31 II 
22 <20 II-III 
 
 
 
Table 5.3 Left ventricular ejection fraction 
and NYHA class of each heart failure patient 
LVEF—left ventricular ejection fraction; NYHA—
New York Heart Association 
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Control Heart Failure 
Sedentary 5 (24) 11 (55)# 
Active Lifestyle 7 (33) 8 (40) 
Highly Active 9 (43) 1 (5)* 
Table 5.4 Physical activity proportions 
All values are n (%); *p<0.05; #p<0.10; control n=21; heart failure n=20 
 52 
 
 
 
 
 
 
 
MoCA items 
Total 
possible 
score 
Heart Failure 
MoCA≥26 MoCA<26 
Age - - 68.5 (63.0-77.0) 67.5 (63.0-78.0) 
Overall score - 30 27.0 (27.0-28.5) 22.5 (21.0-24.0)* 
Short-term 
memory 
delayed recall 5 4.0 (3.0-4.0) 1.0 (1.0-3.0)* 
Visuospatial 
function 
clock, cube 4 4.0 (4.0-4.0) 3.0 (3.0-4.0)* 
Executive 
function 
trails, fluency, 
abstraction 
4 3.5 (3.0-4.0) 2.0 (1.0-3.0)* 
Attention, 
Concentration, 
Working memory 
digit, serial 7, letter 6 6.0 (5.0-6.0) 5.0 (5.0-6.0) 
Language 
naming, sentence 
repetition, fluency 
6 6.0 (4.5-6.0) 4.0 (4.0-5.0)* 
Orientation orientation 6 6.0 (5.5-6.0) 6.0 (6.0-6.0) 
Table 5.5 Montreal cognitive assessment cognitive domain median scores for patients with 
normal and abnormal total scores 
All values are median (interquartile range); *p<0.05. MoCA—Montreal Cognitive Assessment; 
MoCA ≥ 26 n=8; MoCA < 26 n=14 
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 Control Heart Failure 
HR (bpm) 56 (50-65) 60 (54-69) 
MAP (mmHg) 95 (87-102) 89 (83-99) 
Qi_Fin (L/min/m2) 4.8 (4.1-6.1) 2.7 (2.4-4.3)* 
SVi (mL/beat/m2) 80 (62-96) 48 (34-71)* 
TPR (mmHg/L/min) 18 (16-22) 17 (11-24) 
MFVMCA (cm/s) 51 (44-55) 43 (34-60) 
SFVMCA (cm/s) 77 (69-82) 74 (61-94) 
DFVMCA (cm/s) 31 (28-35) 24 (19-32)* 
CVRi (mmHg/cm/s) 1.9 (1.7-2.1) 2.0 (1.7-2.3) 
RI 0.6 (0.5-0.6) 0.7 (0.6-0.7)* 
PI 0.9 (0.7-0.9) 1.2 (1.0-1.3)* 
CBFRICA (mL/min) 296 (255-343) 264 (214-313) 
CBFLICA (mL/min) 293 (250-333) 235 (224-267)* 
aCBF (mL/min) 627 (546-679) 479 (447-590)* 
ETCO2 (mmHg) 37 (33-40) 35 (32-39) 
PPbrach (mmHg) 56 (45-66) 61 (47-77) 
PPcar (mmHg) 50 (41-53) 61 (48-64)# 
IMTmean (mm) 0.60 (0.55-0.76) 0.78 (0.62-0.88)* 
 
 
 
 
 
Table 5.6 Median values for cardiovascular and cerebrovascular variables in control and 
heart failure patients in the supine position 
All values are median (interquartile range); *p<0.05; #p<0.10.  HR—heart rate n=22; MAP—mean arterial 
pressure n=22; Qi_Fin—cardiac index estimated from the Finometer n=22; SVi—stroke index n=22; 
TPR—total peripheral resistance n=22; MFVMCA—mean flow velocity through the middle cerebral artery 
n=18;  SFVMCA—systolic flow velocity through the middle cerebral artery n=18; DFVMCA—diastolic flow 
velocity through the middle cerebral artery n=18; CVRi—cerebrovascular resistance index n=18; RI—
resistance index n=18; PI—pulsatility index n=18; CBFRICA—cerebral blood flow through the right internal 
carotid artery n=19; CBFLICA—cerebral blood flow though the left internal carotid artery n=18; aCBF—
anterior cerebral blood flow through bilateral internal carotid artery n=17; ETCO2—end tidal carbon 
dioxide n=22; PPbrach—brachial pulse pressure n=22; PPcar—carotid pulse pressure n=15; IMTmean—mean 
intima-media thickness n=19 
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 Control Heart Failure 
HR (bpm) 62 (56-66) 60 (53-69) 
MAP (mmHg) 94 (90-104) 93 (84-96) 
Qi_Fin (L/min/m2) 5.3 (4.1-5.7) 2.6 (1.9-3.7)* 
SVi (mL/beat/m2) 77 (60-86) 45 (34-57)* 
TPR (mmHg/L/min) 18 (16-21) 17 (13-24) 
MFVMCA (cm/s) 49 (41-54) 39 (32-53) 
SFVMCA (cm/s) 74 (67-80) 73 (56-93) 
DFVMCA (cm/s) 30 (26-35) 21 (17-29)* 
CVRi (mmHg/cm/s) 1.3 (1.1-1.7) 1.5 (1.4-1.9) 
RI 0.59 (0.56-0.63) 0.69 (0.66-0.72)* 
PI 0.92 (0.83-1.01) 1.27 (1.14-1.31)* 
CBFRICA (mL/min) 282 (255-333) 217 (188-271)* 
ETCO2 (mmHg) 37 (34-38) 34 (32-37) 
 
 
 
 
 
 
Table 5.7 Median values for cardiovascular and cerebrovascular variables in control and 
heart failure patients in the seated position 
All values are median (interquartile range); *p<0.05.  HR—heart rate n=22; MAP—mean arterial pressure 
n=22; Qi_Fin—cardiac index estimated from the Finometer n=22; SVi—stroke index n=22; TPR—total 
peripheral resistance n=22; MFVMCA—mean flow velocity through the middle cerebral artery n=18; 
SFVMCA—systolic flow velocity through the middle cerebral artery n=18; DFVMCA—diastolic flow velocity 
through the middle cerebral artery n=18; CVRi—cerebrovascular resistance index n=18; RI—resistance 
index n=18; PI—pulsatility index n=18; CBFRICA—cerebral blood flow through the right internal carotid 
artery n=19; ETCO2—end tidal carbon dioxide n=22 
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Figure 5.1 Absolute values and individual data for cardiovascular responses to supine and 
seated positions in control and heart failure patients White bars represent the supine position and 
grey bars represent the seated position. The boundary of the box closest to zero indicates the 25th 
percentile, a line within the box marks the median, and the boundary of the box farthest from zero 
indicates the 75th percentile. The error bars above and below the box designate the 90th and 10th 
percentile. Each control and heart failure patient’s response is displayed on the graph as the individual 
lines; n=22 for all variables; HR—heart rate; SVi—stroke volume index; Qi_Fin—cardiac index estimated 
from the Finometer; TPR—total peripheral pressure; MAP—mean arterial pressure 
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Figure 5.2 Absolute values and individual data for cerebrovascular responses to supine and 
seated positions in control and heart failure patients Graph format is the same as described in 
Figure 5.1.  MFVMCA—mean flow velocity from the middle cerebral artery n=18; CVRi—cerebrovascular 
resistance index n=18; RI—resistance index n=18; PI—pulsatility index n=18; ETCO2—end tidal carbon 
dioxide n=22; CBFRICA—cerebral blood flow through the right ICA n=19 
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Figure 5.3 Change in cardiovascular responses from a supine to a seated position in 
controls and heart failure patients The boundary of the box closest to zero indicates the 25th percentile, a 
line within the box marks the median, and the boundary of the box farthest from zero indicates the 75
th
 percentile. 
The error bars above and below the box designate the 90
th
 and 10
th
 percentile. Each control and heart failure 
patient’s response is displayed on the graph as individual dots; n=22 for all variables; HR—heart rate; SVi—stroke 
volume index; Qi_Fin—cardiac index estimated from the Finometer; TPR—total peripheral pressure; MAP—mean 
arterial pressure; * indicates significant difference from controls p<0.05 
* 
 58 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.4 Change in cerebrovascular responses from a supine to a seated position in controls 
and heart failure patients Graph format is the same as described in Figure 5.3; MFVMCA—mean flow velocity 
through the middle cerebral artery n=18; CVRi—cerebrovascular resistance index n=18; RI—resistance index n=18; 
PI—pulsatility index n=18; ETCO2—end tidal carbon dioxide n=22; CBFRICA—cerebral blood flow through the right ICA 
n=19. * indicates significant difference from controls p<0.05 
* 
* 
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0-back 1-back 
Supine Seated Supine Seated 
Omissions 
0 
(0-0) 
0 
(0-0) 
0 
(0-0) 
0 
(0-0) 
Commissions 
0 
(1-0) 
0 
(0-0) 
0 
(0-0) 
0 
(0-0) 
Accuracy (%) 
100 
(83-100) 
100 
(100-100) 
100 
(100-100) 
100 
(100-100) 
Reaction time (ms) 1018 
(921-1177) 
1028 
(938-1089) 
1070 
(993-1123) 
1038 
(910-1135) 
Table 5.8 Cognitive outcomes for the 0-back and 1-back in the supine and 
seated positions for heart failure patients 
All values are median (interquartile range); n=21 
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0-back 1-back 2-back 
Supine Sit Supine Sit Supine Sit 
Omissions 
0 
(0-0) 
0 
(0-0) 
0 
(0-0) 
0 
(0-0) 
1.5 
(1-2) 
1 
(1-1) 
Commissions 
0 
(0-0) 
0 
(0-0) 
0 
(0-0) 
0 
(0-0) 
1 
(0-1) 
0 
(0-1) 
Accuracy (%) 
100 
(100-100) 
100 
(100-100) 
100 
(100-100) 
100 
(100-100) 
67* 
(50-83) 
83* 
(67-83) 
Reaction 
time (ms) 
961 
(819-1170) 
1002 
(908-1141) 
1053 
(917-1089) 
973 
(903-1102) 
1063 
(968-1274) 
1048 
(1020-1318) 
Table 5.9 Cognitive outcomes for the 0-back, 1-back and 2-back in the supine and seated 
positions for heart failure patients 
All values are median (interquartile range); n=10; *p<0.05 
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* 
* 
* 
* 
# # 
Figure 5.5 Change in mean flow velocity, mean arterial pressure and heart rate from 
baseline to cognitive load in supine and seated positions for heart failure patients The 
boundary of the box closest to zero indicates the 25
th
 percentile, a line within the box marks the median, and the 
boundary of the box farthest from zero indicates the 75
th
 percentile. The error bars above and below the box 
designate the 90
th
 and 10
th
 percentile. Each heart failure patient’s response is displayed on the graph as individual 
dots; MFV—mean flow velocity (0-back n=17, 1-back n=16, 2-back n=10); MAP—mean arterial pressure (0-back 
n=21, 1-back n=21, 2-back n=10); HR—heart rate (0-back n=21, 1-back n=21, 2-back n=10). * indicates significant 
difference from controls p<0.05; # indicates a trend to be different from controls p<0.10 
0-back 1-back 2-back 
∆
 
∆
 ∆
 
∆
 
∆
 ∆
 
∆
 
∆
 
∆
 
* 
* * 
# # 
* 
# 
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 0-back 1-back 2-back 
∆ Qi_Fin (L/min/m2) 0.289 0.414 0.910 
∆ SVi (mL/beat/m2) 0.140 0.348 0.232 
∆ TPR (mmHg/L/min) 0.052 # 0.164 0.322 
∆ CVRi (mmHg/cm/s) 0.263 0.712 0.250 
∆ RI 0.144 0.715 0.129 
∆ PI 0.304 0.900 0.232 
∆ ETCO2 (mmHg) 0.142 0.442 0.688 
 
 
 
 
 
 
 
 
 
 
 
Table 5.10 Statistical p-values for the comparison between supine and 
seated positions for various cognitive loads in heart failure patients 
Values are p-values. #p<0.10. Qi_Fin—cardiac index estimated from the Finometer (0-
back n=21, 1-back n=21, 2-back n=10); SVi –stroke index (0-back n=21, 1-back n=21, 2-
back n=10); TPR—total peripheral resistance (0-back n=21, 1-back n=21, 2-back n=10); 
CVRi—cerebrovascular resistance index (0-back n=17, 1-back n=16, 2-back n=10); RI—
resistance index (0-back n=17, 1-back n=16, 2-back n=10); PI—pulsatility index (0-back 
n=17, 1-back n=16, 2-back n=10); ETCO2—end tidal carbon dioxide (0-back n=21, 1-
back n=21, 2-back n=10) 
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Figure 5.6 Relationship between age and supine anterior cerebral blood flow 
in heart failure patients 
A greater age was inversely associated with a lower anterior cerebral blood flow (aCBF) 
through the bilateral internal carotid arteries. p=0.017; rs=-0.58; n=16 
Figure 5.7 Relationship between age and MoCA score in heart failure patients 
There was no relationship detected between MoCA score and age. p=0.423; rs=-0.18; n=22 
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Figure 5.8 Relationship between left ventricular ejection fraction and 
supine cardiac index from the Finometer in heart failure patients 
No relationship between supine left ventricular ejection fraction (LVEF) and supine 
cardiac index from the Finometer (Qi_Fin). p=0.848; rs=0.0427; n=22 
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Figure 5.9 Relationship between left ventricular ejection fraction and MoCA 
score in heart failure patients 
There was a low to moderate inverse relationship detected between left ventricular 
ejection fraction (LVEF) and MoCA score that did not reach statistical significance. 
p=0.240; rs=-0.30; n=22 
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Figure 5.10 Relationship between left ventricular ejection fraction and supine 
anterior cerebral blood flow in heart failure patients 
No relationship was identified between left ventricular ejection fraction (LVEF) and supine 
anterior cerebral blood flow (aCBF) through the bilateral internal carotid arteries. p=0.805; 
rs=0.06; n=16 
Figure 5.11 Relationship between supine cardiac output and supine anterior cerebral 
blood flow 
A significant positive correlation was identified between supine cardiac output from the 
Finometer (Qi_Fin) and supine anterior cerebral blood flow through the bilateral internal carotid 
arteries. p=0.047; rs=0.50; n=16 
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Heart Failure 
Heart Failure with 
Atrial Fibrillation 
Age (years) 71±8 72±8 
Sex males n(%) 3 (75) 3 (75) 
Height (cm) 180±16 174±11 
Weight (kg) 91±26 87±22 
BMI (kg/m2) 28±6 28±6 
MoCA 26±3 23±3 
(1)LVEF / NYHA <40 / II 55 / I-II 
(2)LVEF / NYHA 35-40 / II 45 / II 
(3)LVEF / NYHA 25-30 / II 56 / III 
(4)LVEF / NYHA 27 / II <20 / II-III 
 
 
 
 
 
 
 
 
Table 5.11 Patient characteristics for heart failure patients matched to 
those with heart failure and atrial fibrillation 
Values are represented as mean ± standard deviation unless otherwise stated, n=4. 
BMI—body mass index; MoCA—Montreal Cognitive Assessment; LVEF—left ventricular 
ejection fraction; NYHA—New York heart association 
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 Heart Failure 
Heart Failure with 
Atrial Fibrillation  
Diabetes  1 (25) 1 (25) 
β-blocker  4 (100) 4 (100) 
Ace inhibitor  2 (50) 2 (50) 
ANGII receptor blocker 2 (50) 1 (25) 
Diuretic 3 (75) 4 (100) 
Ca+2 Channel blocker 1 (25) 0 (0) 
Statin 3 (75) 3 (75) 
Warfarin 0 (0) 3 (75) 
Aspirin 1 (25) 1 (25) 
Plavix 3 (75) 0 (0) 
Antiarrhythmic agent 0 (0) 2 (50) 
 
 
 
 
 
 
 
 
Table 5.12 Medical characteristics for heart failure patients matched to 
those with heart failure and atrial fibrillation 
Values are represented as n(%); n=4 
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A. B. 
Figure 5.12 Representative beat-by-beat output in the supine position from a patient with 
heart failure and a patient with heart failure and atrial fibrillation 
The heart failure patient (A) was male, 67 years old and had a left ventricular ejection fraction of 27%. 
The heart failure patient with atrial fibrillation (B) was male, 67 years old and had a left ventricular 
ejection fraction of <20%. As a consequence of the atrial fibrillation, evident in the electrocardiogram 
(ECG) in column B, the patient had much more variation in his arterial blood pressure (ABP), mean 
flow velocity from the middle cerebral artery (MFVMCA) and cardiac index from the Finometer (Qi_Fin). 
Qi_Fin variation is illustrating the variation of Qi_Fin around the mean value 
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Heart Failure 
Heart Failure with Atrial 
Fibrillation 
Average Average 
standard 
deviation 
Average Average 
standard 
deviation 
HR (bpm) 60 1.5 67 17.4 
MAP (mmHg) 98 3.5 83 5.3 
Qi_Fin (L/min/m2) 2.9 0.1 2.6 0.7 
SVi (mL/beat/m2) 49 2.1 42 8.3 
TPR (mmHg/L/min) 17 1.4 18 6.7 
MFVMCA (cm/s) 56 2.8 49 4.9 
CVRi (mmHg/cm/s) 1.9 0.09 1.8 0.17 
RI 0.6 0.03 0.6 0.07 
PI 1.0 0.08 1.1 0.22 
ETCO2 (mmHg) 36 1.6 34 2.1 
 
 
 
 
 
 
 
 
Table 5.13 Mean supine values and mean variation for heart failure patients and heart 
failure patients with atrial fibrillation  
Values are represented as means. HR—heart rate n=4; MAP—mean arterial pressure n=4; Qi_Fin—
cardiac index estimated from the Finometer n=4; SVi—stroke index n=4; TPR—total peripheral 
resistance n=4; MFVMCA—mean flow velocity through the middle cerebral artery n=3; CVRi—
cerebrovascular resistance index n=3; RI—resistance index n=3; PI—pulsatility index n=3; ETCO2—
end tidal carbon dioxide n=4 
 71 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A. 
B. 
MFVRICA=29.9cm/s; d=0.48cm; CBFRICA=325mL/min 
MFVRICA=15.4cm/s; d=0.67cm; CBFRICA=322mL/min 
Figure 5.13 Representative supine velocity tracing from the right internal carotid artery in a 
patient with heart failure (A) and a patient with heart failure and atrial fibrillation (B) 
These data are from the same patients described in figure 5.12. This illustrates that despite having a 
lower mean flow velocity, evident here through the internal carotid artery (MFVRICA) and in Figure 5.12 
through the middle cerebral artery, cerebral blood flow (CBFRICA) through the ICA is maintained since the 
diameter (d) of the artery is larger 
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6.0 Discussion 
The primary objective of this thesis were successfully met by (1) investigating how CBF 
changes in response to an upright posture in heart failure patients compared to age- and sex-
matched controls and (2) comparing the difference in cognitive outcomes and cognitive-activated 
hemodynamics between supine and seated in the heart failure sample. Our hypothesis was 
confirmed by the finding that CBF decreased more in response to sitting upright in the heart 
failure group compared to healthy age- and sex-matched controls. Additionally, Q more 
consistently decreased in the heart failure patients in response to the orthostatic stress compared 
to controls. This intermittent cerebral hypoperfusion may further insult the already reduced 
supine CBF and contribute to cognitive impairments over time. Within the heart failure patients, 
performance outcomes on the n-back cognitive task were posture-independent, that is, they did 
not perform worse when upright, differing from our initial hypothesis. In contrast, the n-back or 
cognitive-activated hemodynamics were dependent on posture. Specifically, MFVMCA increased 
significantly less in response to the cognitive task while seated; HR and MAP showed similar 
trends but were not significant. While this confirmed the original hypothesis, a learning effect is 
recognized as a potential confounding factor.  
Furthermore, secondary hypotheses were verified through the inclusion of a spectrum of 
LVEF and patients with atrial fibrillation with coexisting heart failure. LVEF was low-
moderately and inversely related to lower MoCA scores, although not reaching statistical 
significance. We further detected no correlation between LVEF and Qi_Fin or LVEF and supine 
aCBF in agreement with the hypothesis. A positive correlation was detected between supine 
Qi_Fin and supine aCBF suggesting that Q rather than LVEF may better predict those at risk for 
cerebral hypoperfusion that, over time, can contribute to cognitive decline. Last, the hypothesis 
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of high Qi and MFV variability in atrial fibrillation with co-existing heart failure was confirmed. 
This has important implications as a potential contributor to the cognitive impairments observed 
in atrial fibrillation.  
6.1 Posture Effects on Hemodynamics in Heart Failure (Primary Objective 1) 
The primary focus of the current thesis was to determine the effect of an upright posture 
on CBF in heart failure patients compared to age- and sex-matched healthy controls. It was 
hypothesized that the heart failure group would have a greater drop in CBF upon moving to an 
upright seated posture compared with a control group. This hypothesis was supported as the 
median CBFRICA was reduced significantly more in the heart failure group (-29 mL/min) 
compared to the controls (-7 mL/min). In addition to the effect on upright CBF, the 
cerebrovascular and cardiovascular baseline supine measures in the heart failure patients differed 
from the controls in several ways. The following sections will address cerebrovascular (section 
6.1.1) and cardiovascular (section 6.1.2) differences between the heart failure and control groups 
in the supine baseline condition as well as in response to an upright seated position. Differences 
in vascular structure and function will also be discussed (section 6.1.3). Also included are the 
proposed mechanisms linking cardiac dysfunction, cerebral hypoperfusion and cognitive 
impairments (section 6.1.4). 
6.1.1 Cerebrovascular differences between heart failure and controls 
Supine Baseline 
Consistent with previous work (Loncar et al., 2011) we confirmed a lower supine CBF in 
heart failure (479 mL/min) compared to controls (627 mL/min) when measured by ultrasound. In 
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contrast to the ultrasound flow measurement, MFVMCA determined using TCD was not 
statistically different between the groups in spite of being lower by 8cm/s in the heart failure 
group compared to controls. Vogels and colleagues reported MFVMCA to be 9cm/s lower in a 
heart failure group compared to controls, a difference which they reported to be significant 
(Vogels et al., 2008). Small sample size, high variability and the large age range in our sample 
are likely candidates for the inability to detect significant differences. A further consideration is 
that TCD is a measure of MFV and not CBF due to the inability to quantify MCA diameter. In 
order to use TCD as a surrogate of CBF, MCA diameter must be assumed constant. However, 
under extreme conditions (prolonged hypoxia and maximum hypercapnia) and certain disease 
states, MCA diameter does change (Valdueza et al., 1999; Willie et al., 2012). While no reports 
exist on changing MCA diameter in heart failure, age and atherosclerosis related structural 
changes likely affect the intracranial vessels (Ozdogmus et al., 2008). In fact, the PI of the MCA 
was elevated in heart failure as indicated by this study (discussion below) and others (Vogels et 
al., 2008) and has been reported to be directly related to artery stiffness (Webb et al., 2012). 
Thus, changes in MCA diameter may occur in heart failure and are unaccounted for by using 
TCD, although this remains speculative.  
The indices of resistance (RI and PI) were higher in the heart failure patients compared to 
controls in the supine position. This may be partly explained by the lower supine DFVMCA in the 
heart failure group, implying downstream vasoconstriction leading to higher cerebral resistance. 
It is important to note that these indices are independent of pressure so caution must be taken 
when making conclusions on resistance based solely on these indices (Richards et al., 1998). The 
finding of higher resistance indices (RI and PI) could also be due to the elevated arterial stiffness 
or a smaller cross sectional area of the vessel. Utilization of PI and RI as estimates of resistance 
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in the cerebral circulation has been questioned for their ability to solely reflect changes in 
downstream resistance (Czosnyka et al., 1996); rather, in addition to resistance, they represent a 
combination of cerebral perfusion pressure, compliance of the cerebral arterial bed and HR (de 
Riva et al., 2012). CVRi is an alternate resistance index to RI and PI and was unchanged 
between groups in this study. Although this index is also limited as it assumes blood flow to 
continue at pressures approaching 0 mmHg. Alternatively, the calculation of critical closing 
pressure, a linear extrapolation to the pressure at which blood flow would theoretically cease, in 
the determination of cerebral perfusion pressure has been deemed more physiologically relevant 
(Weyland et al., 2000; Carey et al., 2001). A vascular resistance measure, resistance area 
product, can then be calculated by incorporating critical closing pressure. These measures have 
shown promise in understanding cerebral regulation (Weyland et al., 2000). Future studies with 
this population should consider these calculations in order to gain more accurate estimates of 
cerebrovascular resistance changes. 
Upright Posture 
The seated position resulted in a greater increase in PI in the heart failure group 
compared to controls. PI has been found to increase in an elderly population compared to a 
young population upon moving to a seated position (Edgell et al., 2012) and the results from this 
thesis suggest a further elevation in heart failure patients compared to the control group 
collected. A trend was detected for DFVMCA to be reduced more when upright in the heart failure 
patients compared to controls and is a likely contributor to the elevated PI in this group.  
For the first time, CBFRICA was found to decrease more when upright in heart failure 
patients compared to healthy controls. The heart failure group also experienced a greater and 
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more consistent decrease in Q with the upright position compared to the controls.  Previous 
reports have highlighted the reliance of CBF on Q, specifically by using exercise as a mechanism 
to increase Q. One study found that when Q was limited, such as with cardiac pathology, 
cerebral perfusion could not increase during moderate exercise (Ide et al., 1998). This was 
further confirmed in another study that decreased or increased Q with LBNP or serum albumin, 
respectively, and observed concomitant changes in MFVMCA during rest and during exercise 
(Ogoh et al., 2005). Specifically in heart failure patients, one-legged exercise could not elicit the 
same 20% increase in MFVMCA that was seen in controls (Hellstrom et al., 1997). These results 
suggest that, when challenged, blood flow to the brain could not increase when Q was 
compromised. When heart function is improved, such as with a transplant, Q is increased along 
with CBF (Gruhn et al., 2001).  Taken together, results from this thesis along with previous 
findings suggest a dependency of CBF on Q especially when Q is lowered, such as with heart 
failure. Another possibility is the lack of cerebrovascular reserve capacity. The reduction in Q 
that is innate to heart failure may require dilation of brain arterioles while resting to maintain 
blood flow to the brain limiting the potential for further dilation when challenged. In fact, 
Georgiadis and colleagues have reported impaired cerebrovascular reactivity in patients with 
chronic heart failure (Georgiadis et al., 2000). However it should be noted that cerebrovascular 
reactivity measures the response to a metabolic challenge, normally CO2, rather than a pressure 
change. In response to the upright position, heart failure and controls exhibited a statistically 
similar decrease in ETCO2. The decrease in ETCO2 observed with the posture change was small 
and likely contributed little to the CBF response. Cerebral autoregulation, the built in mechanism 
to maintain CBF in the face of fluctuating pressure represents a research area to be explored in 
the heart failure population. Cerebral autoregulation limits are also known to change with 
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pathological states, such as hypertension (Iadecola & Davisson, 2008) and impairments have also 
been reported in diabetes (Bentsen et al., 1975). More work is needed to determine cerebral 
autoregulation functioning in heart failure.  
6.1.2 Cardiovascular differences between heart failure and controls 
Supine Baseline 
By definition, heart failure is associated with low Q due to impairment in the heart’s 
ability to pump or fill. Heart failure patients had a significantly lower supine Qi_Fin (2.7 
L/min/m
2
) compared to healthy controls (4.8 L/min/m
2
), a finding that has been reported by 
others (Carlsson et al., 2012). Interestingly, a significant relationship was detected between 
Qi_fin and supine aCBF in the heart failure patients (Figure 5.11). The dependency of the brain 
on Q is highlighted by the fact that it receives 15-20% of Q at rest but only represents 2% of 
overall body mass (Silverthorn, 2007). Low Q (<4.0 L/min) has been previously associated with 
cognitive (Jefferson et al., 2007a) and neuroimaging abnormalities (Jefferson et al., 2007b).  
Significantly lower brain volumes are detected at Qi <2.9 L/min/m
2 
and therefore this has been 
suggested as a possible clinical threshold associated with abnormal brain aging (Jefferson et al., 
2010). Absolute supine values of Qi obtained in this study were plotted against the change in 
CBFRICA from supine to seated for heart failure patients and controls. The relationship appears to 
be non-linear and fit better to an exponential non-linear model (non-linear r=0.53, linear r=0.35). 
Figure 6.1 suggests that beyond a Qi of ~3.0-4.0 L/min/m
2
 there is an apparent smaller CBF 
change. Therefore, a lower hearts ability (indicated by low Qi) may increase the risk for a greater 
change in CBF when moving to an upright posture.  
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Upright Posture 
The healthy control group increased their HR significantly more than the heart failure 
group, which is consistent with previous literature (Levine et al., 1983; Cody et al., 1982). In the 
1980’s reports on the abnormal response to prolonged tilt in heart failure surfaced, since then 
little work has been done in this area. These early studies found attenuated neurohumoral 
compensatory responses to the passive, prolonged orthostatic stress. Heart failure patients 
exhibited no change in plasma norepinephrine and no increase in HR or plasma renin that were 
documented to increase in the healthy control group (Levine et al., 1983). These irregular 
responses are speculated to be due to maximal stimulation of compensatory mechanisms while 
resting. To our knowledge, this is the first time a more active orthostatic challenge representative 
∆
 
Figure 6.1 Comparison of absolute cardiac index from the Finometer to the 
change in cerebral blood flow through the right internal carotid artery A non-
linear exponential relationship was detected (r=0.53, p=0.018, n=35). This suggests that a 
lower supine cardiac index (Qi_Fin) is associated with a greater drop in cerebral blood flow 
(CBFRICA) when moving to an upright position. 
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of everyday postures has been investigated as well as the inclusion of CBF. In our study design, 
humoral responses from the RAAS are unlikely contributors to the initial posture response since 
there were only 5-10 minutes in the upright posture prior to data collection. Impairments would 
rather be attributed to the changes in the arterial and cardiopulmonary baroreceptors with heart 
failure (Creager & Creager, 1994). Both heart failure and control groups were able to maintain 
MAP in the upright position through an increase in TPR in order to compensate for the drop in 
Q. In spite of the smaller increase in HR with heart failure, MAP at heart level was maintained 
because of the sufficient increase in resistance. Although baroreflex function was not specifically 
tested, it appears the response was appropriate in this sample. A larger challenge to pressure such 
as during prolonged passive head up tilt may exposure insufficiencies in this system but 
importantly, the blood pressure response to a normal every day postural challenge seemed 
sufficient. 
6.1.3 Vascular Structure and Function Differences while Supine between Heart Failure and 
Controls 
Structural and functional differences were found between heart failure and control 
groups. The PP in the CCA (a central elastic artery) was greater in the heart failure group 
compared to the controls whereas PP in the brachial (a distal muscular artery) was comparable. 
Wall thickness, as indicated by IMT, was also found to be greater in the heart failure patients 
compared to healthy controls. Consistent with these results, heart failure has also been found to 
be associated with significant arterial wall thickening and decreased compliance measured at the 
CCA (Lage et al., 1994). In the same study, norepinephrine was found correlated with arterial 
compliance, suggesting the sympathetic nervous system over activity in heart failure may 
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contribute to the arterial stiffening in heart failure (Lage et al., 1994). Arterial stiffness and wall 
thickening have been associated with adverse outcomes in normal aging and pathological states. 
In well-functioning, community dwelling older adults, arterial stiffness is associated with higher 
CVD morbidity and mortality (Sutton-Tyrrell et al., 2005). These findings are exacerbated in the 
setting of systemic hypertension (Laurent et al., 2001). Arterial stiffness also predicts mortality 
and is a risk factor for hospital re-admission (Demir et al., 2013; Meguro et al., 2009). Arterial 
stiffness and carotid wall thickening have been reported to contribute to lower CBF (Tarumi et 
al., 2011; Sojkova et al., 2010) 
6.1.4 Linking Heart Dysfunction and Cerebral Functioning 
This study and others have documented cerebral hypoperfusion and cognitive decline in 
heart failure; but how are the two linked? The exact mechanism is yet to be determined. In 1993, 
de la Torre published a number of papers leading to the proposition of the CATCH hypothesis—
critically attained threshold of cerebral hypoperfusion (de la Torre & Mussivand, 1993). Their 
model suggests that the presence of vascular risk factors further diminish CBF in individuals 
with already diminishing cerebral perfusion with advancing age (de la Torre & Mussivand, 
1993). This two-fold burden on CBF leads to a neuronal energy crisis due to the reduced delivery 
of glucose associated with cerebral hypoperfusion. The energy starved neurons undergo 
oxidative and endoplasmic reticulum stress that ultimately reduces the main fuel for cells—ATP. 
The reduction in ATP impacts post-translational steps, namely protein synthesis, assembly and 
folding. Defects in any of these steps results in dysfunctional or non-functional proteins. 
Irregular protein cleavage and degradation ultimately leads to the build-up of beta-amyloid 
containing plaques, which are found in the brains of patients suffering from Alzheimer’s disease. 
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The under perfused state prevents washout further contributing to the build up of plaques and 
they eventually congregate to form senile plaques. The initial neuronal energy crisis presents 
initially as mild memory impairments but as time progresses and damage accumulates the 
cerebral hypometabolic state lends to the development of dementia and Alzheimer’s disease. 
Support for this theory comes from a recent study that utilized right carotid artery permanent 
ligation to induce mild chronic hypoperfusion in mice (Elali et al., 2013). The researchers found 
that chronic dysfunction of the neurovascular unit and early vascular deposition of beta-amyloid 
peptides. Further evidence of the importance of perfusion is that these alterations were 
essentially prevented by brain reperfusion or the administration of a high dose of glucose (Elali 
et al., 2013). This thesis proposes that upright cerebral hypoperfusion further contributes to the 
declining cognitive state over time by causing intermittent hypoperfusion throughout the day.  
6.2 Cognition (Primary Objective 2) 
 An additional focus of this thesis was to assess cognition and determine if changes could 
be detected in the different postures, supine and seated. It was hypothesized that performance 
outcomes and cognitive-activated hemodynamics in response to a n-back cognitive task would be 
lower in the seated position compared to supine for the heart failure group. The results partly 
disprove the hypothesis as performance on the task was unchanged between supine and seated. 
However, cognitive-activated MFVMCA was lower in the seated position and HR and MAP 
showed similar trends. Moreover, global cognitive functioning was assessed by the MoCA and 
revealed that a high proportion of the heart failure group had some degree of cognitive deficits 
that were not clinically documented.  
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6.2.1 Global Cognition 
Greater than 60% of the heart failure patients were found to have some degree of 
cognitive impairment as detected by a MoCA score of <26. This is slightly higher than previous 
literature which documented that 25-50% of heart failure patients suffer from cognitive deficits 
(Pressler, 2008). Importantly, no cognitive impairments in this sample were previously 
documented formally, suggesting a large portion of mild-moderate cognitive impairments go 
undetected in a clinical setting. This may interfere with the patient’s ability to engage effectively 
in self-care practices and can lead to adverse outcomes. In a recent study, poor self-care was an 
independent risk factor for cardiac events, hospitalizations as well as length of hospital stay 
(Kato et al., 2013). When individual cognitive domains assessed by the MoCA were isolated, 
those with mild-moderate cognitive impairments (MoCA<26) performed worse on the following 
domains: short term memory, visuospatial function, executive function and language. These 
results are consistent with previous literature (Harkness et al., 2011). 
The high prevalence of cognitive impairments contributes to the deterioration of quality 
of life in heart failure. The existence of cognitive impairments is an independent predictor of 
disability, morbidity and mortality and influences one’s ability to perform instrumental activities 
of daily living (Alosco et al., 2012; Zuccala et al., 2003; Zuccala et al., 2001). Moreover, 
depression and slow gait speed in heart failure may further insult outcomes and quality of life. 
Depression, as assessed by the GDS, was significantly greater in the heart failure patients than 
their healthy counterparts; this was conversely associated with a greater proportion of 
antidepressant usage. These results are in agreement with previous reports of high levels of 
depression or depressive symptoms associated with a heart failure diagnosis (Rutledge et al., 
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2006). In addition to higher GDS scores, gait speed, assessed by the 8-m walk test, was lower in 
heart failure. Slow gait has been associated with functional decline in older adults (Cesari et al., 
2005) and has been indicated as a predictor for the onset of disability in patients newly diagnosed 
with heart failure (Chaudhry et al., 2011). A high level of cognitive functioning is required to 
maintain gait with integration required from attention, planning, memory and other processes 
(Scherder et al., 2007) and a decreased gait has been suggested to predict a decline in cognition 
(Marquis et al., 2002). Gait speed has been suggested as a singular measure to assess frailty; 
defined as an increased vulnerability to stressors (Fried et al., 2001). A frail phenotype correlates 
with loss of independence and other patient-centered outcomes (Cacciatore et al., 2005). Frailty 
in heart failure is complex as they frequently co-occur and each condition can exacerbate the 
other (Dodson & Chaudhry, 2012). Therefore, in addition to the high prevalence of cognitive 
impairments in heart failure, depression and frail phenotypes may interact and contribute to a 
decline in quality of life, morbidity and mortality.  
6.2.2 Postural Cognition Outcomes 
Cognitive performance on the n-back task, indicated by the outcome measures of 
commissions, omissions, accuracy and reaction time, was independent of posture and load with 
the exception of accuracy worsening on the 2-back. These findings are distinct from those of 
Stewart et al. (2012) who found the responses to the n-back progressively worsened as 
orthostasis progressed from a tilt angle of 0 to 75 degrees. In this aforementioned study, no 
changes were detected between groups in the unloaded, 0-back condition and changes became 
more distinct with increasing n-back level. In contrast to our study, where the majority of 
patients only completed 0- and 1-back levels, Stewart et al. (2012) had patients and healthy 
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controls perform the n-back up to a cognitive load of 4. With this in mind, the lack of findings 
could be partly due to not administering high enough n-back loads. 
6.2.3 Neurovascular Coupling 
Neuronal activity requires the delivery of oxygen and glucose and therefore is tightly 
linked to increases in CBF (neurovascular coupling). Previous studies have found the n-back 
cognitive task to be sufficient in eliciting an increase in MFVMCA (Stewart et al., 2012; Sorond et 
al., 2011). In a chronic fatigue syndrome patient population, the percent change in CBF 
decreased with increasing tilt angle (Stewart et al., 2012). In comparison, healthy young adults 
(20-30 years old) can increase CBF in response to cognitive tasks independent of the orthostatic 
conditions (Stewart et al., 2012; Azevedo et al., 2007). We found that the neuronal-activated 
increases in MFVMCA were posture-dependent in our heart failure sample, in that there was less 
of an increase in MFVMCA in the seated position. This may be due to the low Q in heart failure 
limiting the absolute amount of blood available to the brain and the ability to increase when 
challenged (Ide et al., 1998). Alternatively, since performance on the task did not change when 
seated, the demand for neuronal activation and consequently cerebral blood flow may have been 
lower due to performing a version of the task previously while supine. 
6.3 Relationships between Measures of Systemic Perfusion, MoCA and Brain Blood Flow 
(Secondary Objective 1) 
A secondary objective of this thesis was to include a spectrum of LVEF’s to determine 
the relationship between LVEF and cognitive, assessed by the MoCA, and CBF. It was 
hypothesized that LVEF would not be correlated with MoCA scores or CBF.  Results confirmed 
no significant relationship between LVEF and cognition, although a low-moderate, inverse 
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relationship appears to be present suggesting that higher LVEF may result in lower MoCA 
scores. Furthermore, no association was detected between LVEF and CBF, confirming the 
hypothesis. It is proposed that Q may better predict cerebral hypoperfusion and identify those at 
risk for cognitive decline.  
LVEF versus Q 
General cardiac function and systemic perfusion are frequently evaluated with LVEF, a 
ratio of ejected blood dependent on end diastolic volume. However, low Q is the main clinical 
outcome of heart failure and  is rarely in agreement with LVEF values (Jefferson, 2010). In fact a 
weak correlation was found between Qi and LVEF in a sample of 157 heart failure patients with 
a LVEF of less than 40% (Carrlson, 2012). Similar, in patients with acute heart failure and a 
broad range of LVEF’s, a weak correlation was also noted between LVEF and Qi (Uriel et al., 
2005). Our results are in agreement with these findings as no relationship was detected between 
LVEF and Qi (Figure 5.8) providing further evidence that a preserved LVEF does not 
necessarily translate to a higher Q.  
Relationship between LVEF and cognition 
A moderate, inverse but non-significant relationship between LVEF and MoCA scores 
was found in the heart failure sample (Figure 5.9). This finding suggests that those with a higher 
LVEF are equally at risk for cognitive deficits. Importantly, the HFpEF subgroup is poorly 
investigated in the literature and consequently has led to a lack of documented knowledge on 
their cognitive state. Recently published studies have found a higher LVEF to be associated with 
worse cognitive functioning in a cross-sectional design (Huijts et al., 2013) and greater decline 
over time in a longitudinal design (Riegel et al., 2012). 
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Systemic perfusion measures and CBF 
No association was found between LVEF and supine aCBF (Figure 5.10) in the heart 
failure sample suggesting that a higher LVEF did not result in an improved CBF as values were 
similar across the LVEF spectrum. On the other hand, an alternative measure of systemic 
perfusion, Qi, showed a significant positive correlation with supine aCBF (Figure 5.11). Similar 
results were presented in a paper by Saha et al. (1993) who found SFVMCA to be significantly 
related to Qi  in a patient population pre or post open-heart surgery (Saha et al., 1993). 
Therefore, Q may better predict those are risk of cognitive decline due to low CBF measures. In 
fact, Q has been related to executive dysfunction and WHM in an elderly population with 
prevalent CVD (Jefferson et al., 2007a; Jefferson et al., 2007b). 
6.4 Atrial Fibrillation (Secondary Objective 2) 
An additional secondary objective of this thesis was to isolate those patients that had 
clinically diagnosed atrial fibrillation in addition to heart failure and determine if they had 
greater variability in Q and brain blood flow due to inherent variations in HR compared to those 
with heart failure alone. High variability in Q and MFVMCA confirmed the hypothesis. While the 
sample size was small, the utilization of effect size calculations suggests promising results with a 
larger sample. In fact, sample size calculations revealed that Qi variability was already 
significantly different between those with and without atrial fibrillation and MFVMCA variability 
significance would be met with the addition of 8 patients to each group.   
Heart failure and atrial fibrillation very often co-exist (Wang et al., 2003) and each is 
known to be associated with cognitive impairments (Ott et al., 1997; Trojano et al., 2003). While 
much attention has been paid to cerebral hypoperfusion in heart failure, most cognitive 
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impairments are attributed to thromboembolic events leading to stroke in atrial fibrillation. Very 
few studies have documented CBF in atrial fibrillation with or without co-existing heart failure 
(Petersen et al., 1989; Porebska et al., 2007) and have yielded some conflicting results. The 
results from this thesis suggest that patients with heart failure and atrial fibrillation have a lower 
unilateral CBF through the RICA (246mL/min) compared to heart failure alone (262mL/min) 
and the healthy control group (296mL/min). The results from Choi and others suggest atrial 
fibrillation is a further insult to CBF in heart failure (Choi et al., 2006). Perhaps just as important 
as the overall decrease in flow is the pulsatility or variability of blood through the cerebral 
vessels. In healthy, older adult population with no history of atrial fibrillation, higher CVD risk 
was associated not only with lower overall flow through the CCA and MCA but also with the 
pulsatility of flow (Pase et al., 2012). Pulsatile flow creates a risk for cognitive impairments 
through cerebrovascular dysfunction due to shearing of the small cerebral vessel endothelium 
during high flow and ischemia during low flow. The variability in Qi and MFVMCA represents an 
underappreciated pathway leading to cognitive impairments independent of stroke in atrial 
fibrillation. 
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7.0 Limitations 
 The entire heart failure sample was being actively treated with medications for heart 
failure, most notably β-blockers (100%), ACE-inhibitors (59%), angiotensin receptor blockers 
(32%) and diuretics (90%). Since it is unethical to take patients off their medications, it would be 
impossible to completely eliminate this potential confound in the setting of this study. However 
it should be noted that a goal of this research was to be inclusive of a sample representative of 
the actual clinical population. The medications listed above are the first line of defence in the 
treatment of heart failure in order to counteract the overactive sympathetic nervous system, 
increase vasodilation and reduce fluid retention. We did not obtain information such as duration 
of heart failure diagnosis or presence of certain co-morbidities. We were provided access to 
clinic space and patient records and made efforts to be as minimally disruptive as possible to 
daily clinic goings-on. Extended time with patient records and/or assistance from clinic staff 
would have been able to uncover more information about medical background of study 
participants. The relatively small sample size in this study needs to be acknowledged specifically 
in the subsets of HFpEF and atrial fibrillation.  Application of the results to these populations 
needs to be made with caution; although promising results do warrant continued investigation. 
Methodological limitations are noted throughout this thesis and include the assumption of 
constant MCA diameter when utilizing the TCD technique (section 4.4.5), using Finometer 
estimates of Q (section 4.7), use of resistance indices (section 6.1) and the lack of posture 
randomization (section 4.7). Importantly, since the postures were not randomized, a learning 
effect on the n-back task cannot be discounted. We did not have data on the postural n-back 
response in a healthy control group (section 6.2) therefore the comparison is limited to between 
postures within the heart failure group. The NYHA class was obtained from patient records in 
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this study. This is a limitation as the classification system is subjective and poorly reproducible. 
Interoperator agreement has been reported to be only 54% even when the same patient was 
assessed on the same day (Raphael et al., 2007). The common point of disagreement is between 
class II and III, the main groups in this study, as they require subjective interpretation of 
“ordinary physical activity” and “slight” and “marked” limitations (Appendix B). 
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8.0 Future Considerations 
This thesis employed a cross-sectional, investigative design. While mechanisms can be 
speculated, further work is needed and warranted to replicate and build upon the results 
presented here. While we found lower supine CBF and a greater decrease in CBF with an upright 
position, an increased understanding of cerebral regulation can be gained in the future by 
incorporating the determination of critical closing pressure and resistance area product. Increases 
in sample size are necessary in all aspects of this study with specific attention to the groups with 
HFpEF and atrial fibrillation. Both of these subsets of the population present unique 
characteristics that require further investigation. Future studies should continue to consider a 
sample representative of the population encountered in every day practice to maximize the 
translatability of the results. Compared to heart failure patients seen in clinical practice defined 
by epidemiology studies, those enrolled in clinical trials are younger, more likely to be male, 
have lower LVEF and generally have fewer co-morbidities (Badano et al., 2003). Women are 
only represented in 21% of heart failure intervention trials despite their rising prognosis of CVD 
(Heiat et al., 2002). The heart failure sample in this thesis was younger and predominantly male 
compared to the ‘real-world patient characteristics’ presented by Badano et al. (2003). While the 
average LVEF in this study (33%) was higher than those from clinical trials (26%), it was still 
slightly lower than that of patients in epidemiology studies (38%). Additionally, the percentage 
of heart failure patients with NYHA class IV is suggested to be 62% (Badano et al., 2003), 
however in this study and others, they have been excluded. These patients are likely hospitalized 
and/or have mobility issues that limit their ability to participant in research studies outside of a 
hospital setting. Therefore, future studies need to be considerate of the ‘real-world’ heart failure 
patient characteristics, specifically, an older age, greater proportion of females and higher LVEF. 
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The results from this study suggest a worsening impact of posture on CBF, raising the 
issue of prevention since heart failure patients are upright during normal daily activities. Exercise 
intolerance is a hallmark of heart failure and is associated with poor prognosis (Pardaens et al., 
2013). A heart failure patient’s ability to increase Q during exercise is severely reduced as a 
consequence of the inability to augment SV as well as a lower maximum HR (Klabunde, 2005). 
Additionally, chronically high sympathetic nervous system activity in heart failure 
downregulates receptors in the heart that increase rate and contraction in response to acute 
sympathetic activation during exercise (Klabunde, 2005). Limited oxygen delivery to working 
muscles and muscle atrophy are further limiting factors (Klabunde, 2005). Together these factors 
contribute to the fatigue and dyspnea experienced by heart failure patients during exertion and 
limit exercise capacity. In this study, the heart failure sample was significantly more sedentary 
than their healthy counterparts when assessed with self-reported questionnaires (Table 5.4). The 
beneficial impact of physical activity in older adults on cardiovascular function is well-
documented and positive effects are also noted in the brain, such as improved cognitive 
performance (Barnes et al., 2003). Brain blood flow is reported to be higher in master athletes 
(Thomas et al., 2013), to increase in response to short term exercise training in previously 
sedentary seniors (Chapman et al., 2013) and even to increase in response to a single exercise 
bout in healthy young adults (MacIntosh et al., 2014). In a study with healthy elderly, a 
physically active lifestyle was found to prevent cerebral vasoconstriction and hypoperfusion 
during an orthostatic challenge (Formes et al., 2010). In CVD and specifically heart failure 
patients, exercise training shows promise at improvements in cognitive function although the 
effect on CBF in this population remain elusive (Tanne et al., 2005; Garcia et al., 2013). Taken 
together, physical activity represents a potential pathway for improving cerebrovascular 
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functioning in heart failure. Exercise intolerance along with other barriers in this population 
represents a significant limitation to research and clinical application in this population.  
Furthermore, it needs to be investigated if this decline in CBF is related to heart failure 
severity. Heart failure patients with a higher NYHA class, a subjective globally used severity 
scale, have been found to have a lower CBF (Choi et al., 2006; Georgiadis et al., 2000). In future 
studies, due to the subjective nature of NYHA classification, the same researcher or clinician 
should classify each study patient. This will eliminate some error with this measurement and 
facilitate the ability to determine the effect of severity on important hemodynamic measures such 
as Q, CBF and functional outcomes such as gait speed. Utilizing Q represents an additional 
pathway to classify severity. A Qi <2.9 L/min/m
2
 has been suggested as a potential clinical cut 
off of accelerated brain aging (Jefferson et al., 2010). We found that an absolute supine Qi of < 
3.0-4.0 L/min/m
2
 was associated with larger changes in CBF when moving to an upright posture. 
Therefore, future investigated into Q as an indicator of abnormal brain changes is justified; 
however, more reliable estimates of Q should be considered. 
The Q estimates from the Finometer were overestimated according to the foreign gas 
rebreathing method obtained from the Innocor (Appendix E). While the Innocor has been 
suggested by some to be effective in a heart failure sample, we found that not all patients were 
able to successfully breathe at the appropriate rate or empty the rebreathing bag which contained 
the required gases to utilize this technique. The benefit to both the Innocor and the Finometer are 
their non-invasive nature in comparison to traditional invasive gold standard measures such as 
the Fick technique or thermodilution that require pulmonary or cardiac catheterization. Future 
consideration should be given to obtaining Q from cardiac ultrasound and/or aortic Doppler as a 
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potentially more reliable method. With dependable Q values we can begin to investigate its 
contribution to functional decline in this population. An important question that remains to be 
answered is whether a critical Qi cut-off (proposed around 3.0 L/min/m
2
) is associated with 
markers of functional decline, such as slow gait speed. Impaired cerebrovascular regulation 
assessed by neurovascular coupling and cerebrovascular reactivity has been found to be 
associated with slow gait speed in community dwelling older adults (Sorond et al., 2011; Sorond 
et al., 2010), however investigation into the heart failure population remains elusive. The low 
CBF in the heart failure population may be related to slow gait and the addition of a cognitive 
task may further divert CBF needed for the complex motor task of walking and lead to falls. 
Research into the relationship between CBF and dual tasking while walking and the relationship 
to falls in heart failure is needed.  
 
 
 
 
 
 
 
 
 94 
 
9.0 Conclusion/Summary 
 In conclusion, this thesis sought primarily to determine if CBF and cognition were lower 
in an upright position in a sample of heart failure patients compared to healthy age- and sex-
matched controls. We found CBFRICA decreased to a greater extent in heart failure patients than 
the controls. We speculate that this reduction is through a Q-dependent mechanism as supine Qi 
and aCBF were found to be correlated in this population. Furthermore, a low absolute supine Qi 
was associated with a greater drop in CBF from supine to seated, to a threshold of approximately 
3.0-4.0 L/min/m
2
. This intermittent cerebral hypoperfusion with upright postures may have 
important implications in contributing to cognitive impairments and Qi may represent an 
important predictive factor for abnormal brain changes. Previous studies have found arterial and 
cardiopulmonary baroreflexes are impaired in heart failure. In spite of a smaller increase in HR 
when moving upright in the heart failure group, MAP was maintained by increased TPR. 
Therefore in response to a normal everyday upright stress, the baroreflex appears sufficient in 
maintaining MAP. In order to assess cognition in different postures in the heart failure group, an 
auditory n-back test was administered while continuing to monitor cardiovascular and 
cerebrovascular hemodynamics. We found that posture had no influence on n-back outcomes but 
that the increase in MFVMCA in response to the cognitive task was lower when upright.  
The secondary objectives of this thesis were to include sub-groups of heart failure 
patients with higher LVEF and atrial fibrillation patients. Within the heart failure sample no 
significant relationship was found between LVEF and MoCA scores; although a low-moderate 
inverse relationship suggests that higher LVEF may be associated with lower MoCA scores in a 
larger sample. Rather than LVEF, resting supine Qi was found to be a better indicator of supine 
CBF. Taken together these results suggest HFpEF patients to be equally at risk for cognitive 
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impairments and that resting supine cerebral hypoperfusion can be better predicted by Qi than 
LVEF in heart failure. In the patients that had atrial fibrillation and co-existing heart failure we 
found higher variability in Qi and MCAMFV. Importantly, this variability in brain blood flow may 
contribute to cognitive decline by damaging the small cerebral vessels endothelium. 
Thromboembolism causing stroke has been primarily attributed for cognitive declines in atrial 
fibrillation, however, changing cerebral hemodynamics may represent an important alternative 
pathway.  
The results from this thesis add novel insights about upright cerebral hemodynamics in 
heart failure. Furthermore, we presented evidence for increasing attention to be brought to 
cerebral hemodynamics and cognition in HFpEF and atrial fibrillation. Unquestionably, this 
research provides the foundation for future work to be done in this area, which will become 
increasingly important as the elderly population continues to rise in the coming years.  
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Appendix A- Comparison of LVEF and Q 
 
 
 
This table taken from Jefferson (2010) illustrates that low ejection fraction does not always 
correspond with low cardiac output. Normal cardiac output was defined as ≥4.0 L/min and 
normal ejection fraction defined as ≥55% (Jefferson, 2010). 
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Appendix B- NYHA classification 
 
Table taken from Raphael et al. (2007) showing the NYHA classifications. This system uses four 
categories to describe the impact of heart failure on daily activities. It is a measure of disease 
severity related to exercise intolerance and is based on subjective measures made by clinicians 
and patients (Raphael et al., 2007). 
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Appendix C- Cerebral Autoregulation 
 
 
 
 
 
 
 
 
This figure from Bellapart and Fraser (2009) is an illustration of the cerebral autoregulation 
curve. Beyond the lower (50mmHg) and upper limit (150mmHg) the homeostatic protection is 
lost and cerebral blood flow changes with cerebral perfusion pressure (Bellapart & Fraser, 2009). 
 
 
 
 
 
 
 
 
50mmHg 150mmHg 
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Appendix D- Comparison of LVEF between clinical trial and real-world patients 
 
 
 
 
 
 
 
 
 
This figure was adapted from Badano and colleagues (Badano et al., 2003).  It shows that 
clinical trial patients tend to have a lower LVEF than those typically seen in clinical practice. 
Similarly, real world patients from epidemiology studies have a higher ejection fraction than 
those investigated in clinical trials. 
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Appendix E- Foreign gas rebreathing technique 
A foreign gas rebreathe method using the Innocor device (Innovision A/S, Odense, 
Denmark) was also used to measure Q. The only requirement of this technique is that the patient 
be capable of understanding instructions from the operator when performing the breathing 
maneuver. Until recently, the foreign gas rebreathe method required a mass spectrometer which 
is expensive, non-portable and complicated for clinical use. The Innocor which uses an infrared 
photoacoustic gas analyzer has made this technique more clinically accessible by making it 
portable, less expensive and easier to operate. In a heart failure sample, the foreign gas rebreathe 
using the Innocor device has been found comparable to gold standard techniques that are 
invasive and timely such as the Fick and thermodilution methods (Dong et al., 2005; Sobanski et 
al., 2008). The Innocor measures the relative levels of two inert gases, one blood soluble and one 
blood insoluble component over approximately 5 respirations or 15 seconds. It is based on the 
principle that the rate of washout of the blood soluble gas from the alveolar space is proportional 
to pulmonary blood flow (PBF) which is equal to Q in the absence of a significant 
intrapulmonary shunt (Innovision, 2013). The insoluble gas is measured to account for the 
accuracy of mixing between the rebreathing bag and alveolar air and also factors that affect the 
distribution of the blood soluble gas including the lung volume from which it disappears.  
In a seated position, the patient breathed an oxygen enriched mixture containing 0.5% 
nitrous oxide (N20; blood soluble gas) and 0.1% sulfur hexafluoride (SF6; blood insoluble) into a 
respiratory valve using a single-use mask with a bacterial filter in a closed circuit system. The 
mask was adjusted to ensure a proper seal to the face with no leaks. A constant ventilation rate 
was ensured by having the patient breathe in synchrony to a metronome set at 15 breaths/min. 
Pulse oximetry was used to detect the presence of significant shunting (arterial oxygen saturation 
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(SpO2) > 95%). The patients first practiced by breathing room air from the mask to the 
metronome for approximately 20-30 seconds to acclimatize to the breathing rate. Once the 
operator was confident the breathing rate could be maintained, the patients were switched into 
breathing the gas mixture from the rebreathing bag at the end of expiration. The ventilation 
volume was held constant by ensuring the patients emptied the rebreathing bag with each breath. 
The bag was monitored and verbal encouragement was given by the operator to breath deeper if 
the bag was not being completely emptied. The rebreathe protocol was repeated twice with at 
least 5 minutes between trials.  
The Innocor rebreathing internal software uses the insoluble gas concentration to account 
for lung volume and incomplete mixing. The first two or three breaths are excluded from the 
analysis as gas mixing is not completely achieved at this point. The slope of the regression line 
through logarithmically transformed N20 end expiration concentrations indicates PBF and thus 
Q. That is, the steeper the slope, the greater the rate of N20 disappearance from the alveoli in the 
lung to the passing blood and the higher the PBF, which is used to indicate Qinn. Height, weight, 
age and sex were entered into the Innocor and consequently a measure of Qiinn was also provided 
in the output from the machine. Successful Innocor trials were performed on eleven patients. One 
person was excluded due to the detection of a pulmonary shunt (SpO2 = 92%), resulting in ten 
patients being included in the analysis. 
A comparison between Qi values from the Finometer (Qi_Fin) and from the Innocor 
(Qi_Inn) is included in the figure below. The Finometer tended to overestimate Qi as the mean 
values from the Finometer and Innocor were 3.2 L/min/m
2 
and 2.0L/min/m
2
, respectively.  The 
seated Qi_Inn was compared to the estimated seated value from Qi_Fin and no relationship was 
detected (figure 5.8; rs=0.39, p=0.243). In this small sample, these results are suggestive of 
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inaccurate estimates from the Finometer in this population, although it appears a relationship 
may be detectable with a larger sample size. Further research is needed to make definite 
conclusions on the accuracy of the Finometer in a heart failure sample 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Relationship between seated cardiac index from the Innocor and seated cardiac 
index from the Finometer 
No relationship between seated cardiac index from the Innocor (Qi_Inn) and seated 
cardiac index from the Finometer (Qi_Fin). p=0.243; rs= 0.389; n=10 
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Appendix F- Take home questionnaire 
Study ID:____________       Date:________________ 
1.  Your Background 
1.   People living in Canada come from many different cultural and racial backgrounds.  
  Are you? (Check (√) all that apply) 
  □ Aboriginal:       □ 1st Nation              □ Inuit             □ Métis 
□ White    □ Black   □ Southeast Asian i.e. Vietnamese  
□ Filipino    □ Chinese        □ South Asian i.e. East Indian/Pakistan  
□ Latin American                    □ Other: _________________________________________ 
2. What language did you first learn to speak as a child? ____________________________ 
3. In what languages can you conduct a conversation?    ____________________________  
4.  What is your birthplace?          City/Town_______________________ Province____   
            If born outside Canada,      Country _________________ years in Canada: _____ 
5. What is your mother’s birthplace?  City/Town ______________________ Province_____ 
             If born outside Canada,         Country ____________________________________  
6. What is your father’s birthplace?    City/Town______________________ Province_____      
If born outside Canada,                  Country____________________________________  
2.  Your Marital Status 
  □ never married 
  □ married or living with a partner 
  □ widowed, not currently married 
  □ divorced, not currently married 
  □ separated 
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3.  Your Education 
1. What are your total years of formal education (includes grades 1 and higher):  
________years  
2. What diplomas, certificates or degrees have you obtained? 
 (Check (√) all that apply) 
   □ None       □ High School             
  □ Trade certificate/diploma  □ Community college diploma  
□ University undergraduate degree □ University graduate degree 
4.  Your Occupation 
1. What kind of work did you do for most of your life? 
______________________________________________________ 
2.  If you did not work for pay, what did your spouse do for most of their life? 
 __________________________________________ 
3.  Are you working for pay now? 
  If yes, please check (√): □ casual 
      □ part time 
      □ full time 
  If no, year last worked ___________  or □ never worked 
5. Sleep Hygiene 
1. How many hours do you sleep within a 24-hour period of time? Please exclude time 
awake overnight but include daytime naps. 
(Check (√) which time most frequently applies to you) 
___6 hours or less 
   ___7 hours 
   ___8 hours 
   ___9 hours or more 
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2. Have you had any of the following symptoms within the last 30 days? 
   Sleeping disorders or insomnia  Yes____   No____ 
   Fatigue and tiredness   Yes____   No____ 
6. Physical Activity 
Physical activity is any form of body movement that requires effort, but does not include 
routine activities of daily living such as self-care and cooking. Physical activity can be 
required for work or transportation, or for pleasure. 
 
The intensity of physical activity refers to the amount of effort you put into the activity. 
It can be judged on a 10-point scale, where ‘0’ is sitting and ‘10’ is all out effort, or it can 
be described in terms of how much you are sweating and breathing. To help us group 
activities together, we split intensity into 3 categories: LIGHT, MODERATE and HARD. 
 
 
 
 
 
 
 
 
 
 
 
 
 
LIGHT:  2-4 on a scale from 0-10.  
No sweating, but faster breathing, e.g. walking. 
 
MODERATE:  5-6 on a scale from 0-10.  
Some sweating and deeper breathing, but still able 
to talk comfortably, e.g. brisk walking or biking. 
 
HARD:  7-8 on a scale from 0-10.  
Heavy sweating and heavy breathing with difficulty 
talking, e.g. running or swimming.  
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1. This question asks you to list specific activities that you have regularly performed during the 
past 4 months. List any regular activity from gardening to running. Circle the appropriate 
Frequency and Duration for each Activity you list.  Intensity might vary within the activity. 
Please indicate the percentage of time you spend at each Intensity for all the Activities you 
list. An example listing has been completed in the first row. 
 
 
Activity 
Description 
 
Frequency 
(# of sessions per 
week) 
Duration 
(minutes per session) 
Intensity 
 (described above) 
E.g. Cycling 1-2    3-4    5+ up to 20   20-30   30-60   60+ 
 
Light   Moderate   Hard 
 50%          50%         0% 
 
 
1-2    3-4    5+ up to 20   20-30   30-60   60+ 
Light   Moderate   Hard 
  ___%     ___%       ___% 
 
 
1-2    3-4    5+ up to 20   20-30   30-60   60+ 
Light   Moderate   Hard 
  ___%     ___%       ___% 
 
 
1-2    3-4    5+ up to 20   20-30   30-60   60+ 
Light   Moderate   Hard 
  ___%     ___%       ___% 
 
 
1-2    3-4    5+ up to 20   20-30   30-60   60+ 
Light   Moderate   Hard 
  ___%     ___%       ___% 
 
 
1-2    3-4    5+ up to 20   20-30   30-60   60+ 
Light   Moderate   Hard 
  ___%     ___%       ___% 
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2. This question asks you about the amount of regular physical activity you perform. Only 
consider activities you perform for at least 20 continuous minutes at a time. Please check 
one box in each intensity category that describes the frequency of your average physical 
activity habits during the past year. 
 
 
        a) I have engaged in LIGHT physical activity:  
   □ No days per week 
 □ 1 to 4 days per week 
 □ At least 5 days per week 
 
       b) I have engaged in MODERATE physical activity: 
   □ No days per week 
 □ 1 or 2 days per week 
 □ 3 or 4 days per week 
 □ At least 5 days per week 
 
       c) I have engaged in HARD physical activity:  
   □ No days per week 
 □ 1 or 2 days per week 
 □ 3 days per week 
 □ At least 4 days per week 
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               d)  I have engaged in activities to increase muscle strength, such 
as lifting weights: 
                       □ No days per week 
 □ 1 or 2 days per week 
 □ 3 days per week 
 □ At least 4 days per week 
 
      e)  I have engaged in activities to improve flexibility, such as 
stretching or yoga: 
                       □ No days per week 
 □ 1 or 2 days per week 
 □ 3 days per week 
 □ At least 4 days per week 
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Appendix G: Geriatric Depression Scale Scoring 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 129 
 
Appendix H: Self-reported physical activity scoring 
 
  a) I have engaged in LIGHT physical activity:  
   □ No days per week 
 □ 1 to 4 days per week 
 □ At least 5 days per week 
 
       b) I have engaged in MODERATE physical activity: 
   □ No days per week 
 □ 1 or 2 days per week 
 □ 3 or 4 days per week 
 □ At least 5 days per week 
 
       c) I have engaged in HARD physical activity:  
   □ No days per week 
 □ 1 or 2 days per week 
 □ 3 days per week 
 □ At least 4 days per week 
 
 
Sedentary   0-2 points 
Active Lifestyle  3-6 points 
Highly Active  >7 points 
 
 
 
 
0 points 
1 point 
2 points 
0 points 
2 points 
3 points 
5 points 
0 points 
3 points 
7 points 
9 points 
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Appendix I: Cerebral Blood Flow and Cardiac Output 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Change in cerebral blood flow in the right internal carotid artery (CBFRICA) and 
cardiac index (Qi) from supine to seated for healthy control and heart failure groups.  
Graphical representation of mean and standard deviation. Heart failure group appears to 
have a larger drop in CBF and Qi from supine to seated; although the large variation is 
noted.  
∆
 ∆
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Appendix J: CBF in heart failure and heart failure with co-existing atrial fibrillation 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A
. 
B
. 
MFVRICA=21.1cm/s; d=0.45cm; CBFRICA=201mL/min 
MFVRICA=24.8cm/s; d=0.44cm; CBFRICA=224mL/min 
The heart failure patient (A) was female, 81 years old and had a left ventricular 
ejection fraction defined as <40%. The heart failure patient with atrial fibrillation (B) 
was female, 82 years old and had a left ventricular ejection fraction defined as 55%. 
This figure illustrates the high variability in the velocity when atrial fibrillation is 
present.  CBFRICA in these particular patients was comparable.   
